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Abstract 
 
Neurons communicate through the release and uptake of excitatory or inhibitory 
neurotransmitters across their synapses. The equilibrium between neuronal synaptic 
neurotransmission and ion concentrations define the functionality of neuronal 
network and the ongoing brain homeostasis. As consequence, the alteration of this 
equilibrium can modify the normal neuronal activity and result in a condition of 
hyperexcitability in the brain. This condition may lead to seizures due to excessive 
and synchronous neuronal activity that cause the interruption of normal behaviour 
and consciousness. While seizures represent the transient manifestation of altered 
brain functions, epilepsy is a chronic neurologic disorder, characterized by two or 
more unprovoked or recurrent seizures caused by genetically predetermined process 
or by an initial insult. Acute and chronic seizures may damage the neuronal cell 
physiology thus prompting a rapid neuroinflammatory response. Studies suggest that 
seizures develop in children with significant higher incidence than in adults, 
indicating that the immature brain is more prone to develop an excessive neuronal 
activity. Although the threshold for seizure generation is lower in the immature brain 
than in the adult brain, due to differences in intrinsic neuronal properties, the 
developing neurons are less vulnerable in terms of neuronal damage and cell loss 
than mature neurons. However, prolonged seizures in immature brain could 
contribute to acute and long-term deleterious effects. Both mature and immature 
rodents have been extensively used to study the cellular and molecular alterations 
linked to seizures. Recently, the contribution of inflammatory reactions to seizure 
induction and progression in epilepsy has been formulated, with a particular focus on 
interleukin 1 beta signalling (IL-1β), suggesting proconvulsant properties of IL-1β in 
acute seizure activity. Unlike these evidences, other works are consistent with an 
acute anticonvulsive function of IL-1β in seizure generation. Moreover, several other 
aspects of the molecular and cellular machineries that promote and define the seizure 
process, and that derive from them, are not clearly understood. As rodents are among 
the most frequently used model organisms for seizure and epilepsy studies, other 
non-mammalian organisms are proposed to tackle these phenomena. Among these, 
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zebrafish is an emerging model system in developmental neurobiology and drug 
discovery. Recent studies have described that both larval and adult zebrafish develop 
seizures when exposed to chemoconvulsant agents, and they present similar profiles 
of responsiveness to anticonvulsant compounds, enlightening the potential of 
zebrafish models for the in vivo study of brain functions and dysfunction. The aim of 
my PhD project is to characterize the induction of seizures in the embryonic brain of 
zebrafish, using a known proconvulsant agent, pentylenetetrazole. First, I have 
described the transcriptional, morphological and behavioural responses associated 
with neuronal hyperactivity during the period of structural and physiological 
maturation of the brain. Then, I have investigated the eventual contribution of 
inflammatory reactions in seizure induction in the zebrafish immature brain, with a 
particular regard to gaining novel insights on the role of IL-1β signalling in seizure 
induction in fish. Altogether, my doctoral work has shown that, in line with other 
animal models, seizures in the immature brain of zebrafish larvae are rapidly 
associated with a neuronal active state and with the induction of a neuroprotective 
mechanism. As far as the inflammatory response is concerned, acute seizures cause 
activation of non-neuronal cells such as astrocytes and, unexpectedly, selective IL-1β 
release and not of other cytokines. This is an unprecedented finding in zebrafish, and 
it is corroborated by genetic manipulation and pharmacological treatments that 
strongly support the hypothesis of a direct role of IL-1β in the maintenance of an 
active state at the neuronal level. 
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CHAPTER 1 
Introduction 
 
1.1. Alteration of Brain Homeostasis: Seizures and Epilepsy 
 
Neurons in the brain communicate which each other through the release and uptake 
of neurotransmitters. These small molecules are released at the synaptic level by 
exocytosis from the pre-synaptic neuron, and bind specific transmembrane receptors 
on the surface of the post-synaptic neuron. Ligand-receptor binding leads to a 
reversible conformational change in the receptor, that could mediate a passage of 
ions flow through it, or activate a cascade of second messengers able to open other 
ion channels, which in turn allows specific ion flux in or out the receiving neurons. 
The main neurotransmitters in the brain are glutamate and gamma amino butyric acid 
(GABA). Glutamate is considered an excitatory neurotransmitter because, upon 
binding its receptors, triggers a positive flow of ions into the neuronal cytoplasm, 
causing depolarization of cell membranes and action potentials. On the contrary, 
GABA receptor binding leads to a chloride influx in the cells that causes membrane 
hyperpolarization, with no firing of action potential. In some circumstances, 
disturbance of the normal balance in the distribution of sodium, potassium, chloride 
or calcium ions across neuronal plasma membranes may cause loss of inhibitory 
neurotransmission or aberrant increase in excitatory neurotransmission (Cloix, 2009). 
As a consequence, the threshold of membrane depolarisation is decreased, 
facilitating the firing of action potentials in the brain. When this balance is disrupted 
in a large number of neurons, they depolarize simultaneously giving raise to seizures. 
The term “seizures” refers to abnormal, synchronized and repetitive burst firing of 
neuronal populations in the central nervous system (CNS) (McNamara, 1994; Shin & 
McNamara, 1994). The seizure is a “transient” alteration of normal neuronal activity 
that affects a restricted area, or that could propagate through the brain. Based on (i) 
the specific brain compartment interested by the onset of seizures, (ii) the pattern of 
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propagation and (iii) the degree of maturity of the brain, seizures may generate 
different behavioural changes and electroencephalograms (Fisher et al., 2005). 
Electroencephalography is a technique based on recording electrodes that measure 
the action potentials produced synchronously by clusters of neurons, thus generating 
an electroencephalogram that illustrates the abnormal neuronal activity. Based on the 
differences in behaviour and electroencephalogram, seizures are classified in 
different ways, according to the International League of Epilepsy, a world’s 
preeminent association of professionals that are interested in understanding and 
diagnosing patients with epilepsy (Fisher et al., 2005; Engel et al., 2001; Berg et al., 
2010). Seizures are described as partial or focal if the onset is localized, or 
generalized if the electrical activity involves the whole brain. Generalized seizures 
are classified in myoclonic, tonic-clonic and absence. Myoclonic seizures are 
characterized by violent muscular contraction, while tonic-clonic seizures produce an 
alternating episode of muscular contraction and relaxation followed by loss of 
consciousness. Absence, on the contrary, is the loss of consciousness and movement 
for few seconds, followed by fast recovery of both. Another type of seizure is Status 
Epilepticus (SE), characterized by continuous seizures lasting more than 30 min. SE 
causes significant mortality and morbidity, including an increased risk to develop 
future epilepsy, and represents an emergency condition (Reddy et al., 2013).  
Epilepsy is a chronic neurologic condition characterized by the presence of recurrent 
unprovoked seizures. It represents a common health problem, because it affects about 
3 million people in the U.S.A. and approximately 65 million people world-wide 
(Jacob et al., 2009) of all ages and both genders. Epilepsy is a complex disorder with 
many possible causes. In the majority of cases (50%), it is idiopathic (unknown 
cause). In the remaining cases, recurrent seizures may result from a variety of 
secondary conditions including trauma, anoxia, metabolic imbalance, CNS infection, 
or can occur as the result of genetic alterations primarily involving ion channels 
(Reddy et al., 2013). The term “epileptogenesis” is used to describe the complex 
plastic changes that convert the non-epileptic neuronal circuit into a seizure-
generating circuit (Vezzani et al., 2007). Epileptogenesis is a slow process that is 
thought to consist of three stages: (i) the initial precipitating event, (ii) the latent 
period, and (iii) the chronic period with spontaneous seizures (Figure 1.1.). Yet, little 
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is known about the exact mechanisms that induce and underlie the development of 
epilepsy. 
The complex context of seizures and epilepsy prompted researchers to study the 
molecular and cellular mechanisms associated with these pathophysiological 
conditions, as well as to discover new therapeutic strategies.  
 
 
Figure 1.1. The pathophysiological stages of epileptogenesis (Reddy et al., 2013). 
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1.2. Animal Models of Seizures and Epilepsy  
 
A choice of chemical, electrical or genetic tools is available to induce epileptic 
seizures or to model epilepsy (Figure 1.2). Chemical models consist in the local or 
systemic administration of agonist or antagonist drugs that mainly target excitatory 
and inhibitory current receptors (De Deyn, 1992). Among these, the most used 
molecules are pentylenetetrazole (PTZ), picrotoxin (PX), pilocarpine and kainic acid 
(KA), which differ about their action mechanism. PTZ and PX are considered non-
competitive antagonists of GABA A receptors that reduce the GABA-mediated 
chloride influx into the neuron, thus preventing neuronal hyperpolarization. KA is a 
L-glutamate analog, and pilocarpine is a muscarinic acetylcholine receptor agonist 
(Kandratavicius et al., 2014). Pilocarpine and KA are used to induce the SE in 
immature and adult rodent models, while PTZ is used to generate acute seizure 
models, therefore its application does not lead to the generation of animal models of 
epilepsy. An important aspect to consider when using PTZ is that seizure models are 
useful for rapid screening of anti-epileptic drug (AED) action, but they do not 
necessarily result in chronic epilepsy (Loscher, 2011). Electrical stimulation is also 
used to induce an alteration of brain homeostasis. One example of electrical 
stimulation is electroshock-induced seizures. This approach features the most studied 
models for electrical seizure stimulation, because it does not require implantation of 
electrodes in the brain, but it consists of a single electrical stimulation of whole brain 
(Landratavicius et al., 2014). In both cases, chemical and electrical tools can be 
differently used to model acute or chronic epileptic seizure conditions. This 
difference is fundamental, because an acute model of seizure, in general, is 
characterized by a single prolonged seizure (SE) in non-epileptic animals such that it 
does not represent a model of epilepsy, while it is rather useful for studying the 
seizure per se (Losher, 2011). On the other hand, chronic models can lead to epilepsy 
generation in terms of spontaneous and recurrent seizures, allowing the study of how 
seizure insults may eventually lead to the development of epilepsy. Kindling is the 
most common chronic model of epilepsy, and it consists of the administration of 
repetitive subconvulsant doses of chemical or electrical stimulation in brain region as 
amygdala or hippocampus that are susceptible to seizure activity. Although the 
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kindling model elicits spontaneous seizures and it is a useful model of epilepsy, it is 
laborious to obtain and time-consuming. Mutant or transgenic animal models that 
carry alterations in genes involved in epilepsy are generally used to study epilepsy 
and to develop therapeutic strategies.  
 
 
 
Figure 1.2. Animal models of epilepsy and epileptic seizures (Loscher, 2011). 
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1.3. New Concepts in Inflammation and Seizure Activity in the Brain  
 
In epilepsy research, adult rodents are extensively studied to characterize the cellular 
and molecular mechanisms underlying the complex process of epileptogenesis. In the 
mature brain, prolonged seizures or SE are often used to generate the inciting event 
and to model some forms of human epilepsy. The consequence of this stimulation is 
an evident loss of vulnerable neurons within the brain region, followed by reactive 
formation of new synapses and abnormal reorganization of neuronal circuits 
(Pitkainen et al., 2002). As neuronal cell loss is considered the triggering event, it has 
been proposed that other factors contribute to the generation of epilepsy. In addition 
to cell death, in fact, the induction of seizures and SE in the rodent brain stimulates 
an extensive inflammatory reaction, that consists in the increased levels of both IL-
1β mRNA and protein and of related cytokines (Plata-Salamàn et al., 2000; Minami 
et al., 1990). The majority of studies in epilepsy research has supported the crucial 
role of cytokines and inflammation in neuronal injury associated with seizure activity 
and in the mechanism of epileptogenesis. More emphasis has been devoted to the IL-
1β cytokine. IL-1β mRNA and protein expression rapidly increase in various brain 
areas after experimentally induced seizures (Vezzani et al., 2002). At the same time, 
IL-1β expression is also increased in the cortex and hippocampus of chronic animal 
models (Minami et al., 1990; Vezzani et al., 1999; Eriksson et al., 2000; Rizzi et al., 
2003), and it is first detected in activated microglia and astrocytes. In the rodent 
epilepsy model, intrahippocampal injection of IL-1β leads to prolonged seizure 
activity, as demonstrated by both electrical and behavioural analyses (Vezzani et al., 
2000), suggesting the proconvulsant role of this cytokine. In support of this 
observation, injection of its natural antagonist IL-1Ra reduces behavioural 
convulsion in a rodent seizure model (Vezzani et al., 2002). In order to verify the 
proconvulsant effect of IL-1β, several studies suggest that excess of IL-1β can 
augment nitric oxide formation and increase neuronal excitability in different ways. 
IL-1β could increase neuronal hyperexcitability by inhibiting GABA A receptor, by 
increasing NMDA receptor function and by inhibiting K
+
 efflux (Viviani et al., 2003; 
Miller et al., 1991; Zhu et al., 2006). However, another group of studies, such as 
those involving intraventricular injection of IL-1β, indicates that IL-1β may have an 
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anticonvulsant activity (Sayyah et al., 2005). In addition, in vitro studies showed that 
IL-1β causes GABA-increase in chloride permeability, and also that IL-1β may 
increase K
+
-evoked GABA release without affecting K
+
-evoked glutamate release, 
acting in the potentiation of GABAergic transmission (Zhu et al., 2006). IL-1β 
involvement in seizure and epilepsy has been reported also in human studies. While 
IL-1β gene polymorphism is associated with an increased susceptibility to seizures 
and epilepsy (Kanemoto et al., 2003), an increased expression of IL-1β and its 
receptor is detected in brain samples from patient s surgically treated for a form of 
refractory epilepsy (Ravizza et al., 2008; reviewed by Li et al., 2011). While 
understanding of the role of the innate immune system in epilepsy and seizure 
threshold changes, and in particular of the associated molecules with inflammatory 
properties, has advanced tremendously over the last decade, yet there are a number of 
questions that remain open and require further investigation (Wilcox and Vezzani, 
2014). 
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1.4. Inflammation in the Brain   
Inflammation refers to the natural body defence reaction to various types of insult 
able to endanger the integrity of cells and tissues. Inflammatory response triggers can 
be an aseptic insult, such as tissue damage caused by mechanical or chemical injury, 
or non aseptic as bacterial or viral invasion. Inflammation consists of a complex 
cascade of events that occur locally within the injured tissue, and eventually 
systemically, and it is closely linked to the activation of the immune system. These 
events include specific signalling mediators, such as cytokines as well as many 
physiological responses, as fever and behavioural changes (Allan and Rothwell, 
2003). The central nervous system (CNS) presents distinctive features and has 
commonly been considered an immune-privileged site. This so-called phenomenon 
of “immune privilege” was recognized in the mid-20th century by Sir Peter Medawar 
who was awarded the Nobel Prize in 1960 together with Sir Frank Macfarlane Burnet 
for the discovery of acquired immune tolerance (Amor et al., 2010). This privileged 
status of the CNS is dependent on several elements, such as an efficient natural 
protection from mechanical aggression by the skull and from biological and chemical 
attack by the presence of a blood–brain barrier (BBB), the lack of a conventional 
lymphatic drainage, and an apparently low traffic of monocytes and lymphocytes 
(Vezzani and Granata, 2005). However, this concept is gradually changing as a result 
of recent developments in the research field of innate immunity that support the role 
of CNS-resident cells acting as innate-immune-competent cells (Aronica et al., 
2012), and that BBB is not a physical barrier that separate the CNS from the 
periphery but it can be stimulated to both release and transmit pro-inflammatory 
mediators and allow leucocyte migration into the brain. This new formulation has led 
to the introduction of the term neuroinflammation to describe a range of immune 
responses in the CNS that differ in several ways from the inflammation in the 
peripheral tissues. The neuroinflammatory response may have beneficial as well 
detrimental consequences in the CNS, principally in the repair and recovery 
processes. Excessive and prolonged neuroinflammatory response can result in 
synaptic impairment and neuronal death, leading to the emerging concept of the 
central role of neuroinflammation in different acute and chronic brain diseases. 
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1.5. Components of Neuroinflammation 
 
The microglial cells are considered the resident macrophages of the brain. These are 
cells of the monocyte/macrophage lineage derived from the embryonic yolk sac that 
invaded the primitive nervous system, the neuroepithelium, from the early 
vasculature. On the basis of their nature, they act as a first line of defence in the 
CNS: they are well equipped to remove debris and apoptotic cells, to respond to 
infectious and non-infectious danger signals and to regulate oxidative processes. 
These brain phagocytic cells are prone to respond to such insults by producing both 
toxic and harmful molecules, particularly cytokines, nitric oxide, growth factor and 
extracellular matrix components, and by taking on the morphology of activated 
macrophages (Perry and Teeling, 2013, Graeber et al., 2011). This activation is 
characterized by alterations in their morphology, such as hypertrophy of the cell 
soma, increased branching, upregulation or de novo synthesis of cell surface or 
intracellular molecules and proliferation (Perry and Teeling, 2013). The role played 
by activated microglia depends on several factors such as the type and duration of the 
activating stimuli, the microenvironment (e.g. the presence of pro- or anti-
inflammatory cytokines) and the interaction with other immune modulators, such as 
astrocytes (Chen et al., 2010).  
 
Unlike microglia, astrocytes descend from neuroepithelial stem cells. These complex 
and highly differentiated cells make a numerous essential contributions to normal 
functions in the healthy CNS, including regulation of blood flow, provision of energy 
metabolites to neurons, participation in synaptic function and plasticity, and 
maintenance of the extracellular balance of ions, fluid and transmitters. In addition, 
astrocytes respond to all forms of CNS insults such as infection, trauma, ischemia 
and neurodegenerative disease by a process commonly referred to as reactive 
astrogliosis (Sofroniew, 2009; Verkhratsky et al., 2013). As reported, the reactive 
astrogliosis is not an all-or-none response, nor a single uniform process, nor it is 
ubiquitously synonymous with scar formation (Sofroniew, 2009). The events 
underlying this process vary with the nature and the severity of insult, in a graded 
progressive alteration that includes molecular expression, cellular hypertrophy and, 
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in severe cases, also proliferation and scar formation. It is defined as a mild and 
moderate form when the reactive astrogliosis exhibits the potential for resolution if 
the triggering mechanism has resolved, because cells return to an appearance similar 
to the one observed in healthy tissues. On the other hand, a severe level of activation 
(in response to tissue damage and inflammation) of reactive astrogliosis involves scar 
formation with new proliferated cells and with overlapping astrocyte processes, in a 
manner not seen in healthy tissue (Figure 1.3A). These responses of reactive 
astrocytes are regulated in a context-specific manner by different signalling events 
that have the potential to modify the astrocyte activities both through gain- and loss-
of-functions that can impact beneficially and/or detrimentally on surrounding neural 
and non-neural cells (Figure 1.3B). 
 
     
 
Figure 1.3. Reactive Astrocytes. A. Photomicrographs of astrocytes in healthy tissue and with 
different gradations of reactive astrogliosis and glial scar formation after tissue insults of different 
types and severity; B. Molecular triggers and modulators of reactive astrogliosis (Sofroniew, 2009). 
 
 
A large number of studies provide different kinds of evidence in vivo and in vitro that 
show that reactive astrocytes can protect CNS cells and tissue in various ways, 
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including the uptake of potentially excitotoxic glutamate (Rothstein, 1996), by 
facilitating blood brain barrier repair (Bush et al., 1999), by stabilizing extracellular 
fluid and ion balance and by reducing seizure threshold (Zador et al., 2009). 
However, reactive astrocytes may also have a proinflammatory potential, as shown 
by studies reporting that deletion or knockdown of certain astrocyte-expressed 
molecules is associated with a reduced inflammation (Okada et al., 2006).  
The mechanisms by which both microglia and astrocytes recognize the presence of 
danger signals involved the expression of an array of germline-encoded pattern-
recognition receptors (PRRs) (Kopitar-Jerala, 2015). This family of receptors include 
principally the membrane-bound toll-like receptors (TLRs) that are able to scan the 
extracellular milieu and endosomal compartments for pathogens-associated 
molecular patterns (PAMPs). PAMPs are lipids, glycolipids, lipoproteins, proteins 
and nucleic acids from a large number of microbial taxa including bacteria, viruses, 
parasites and fungi. All TLRs elicit conserved inflammatory pathways that culminate 
in the activation of the NF-kB and activating protein (AP-1) transcription factors that 
drive pro-inflammatory cytokine/chemokine production (Kawai and Akira, 2006). 
Intracellular nucleic-acid sensing PRRs cooperate with TLRs to provide cytosolic 
surveillance, or an “inward looking”, including the RNA-sensing RIG-like helicases 
(RLHs) and the DNA sensors, DAI and AIM2. A further set of intracellular PRRs are 
the NOD-like receptors (NLRs) that are able to recognize endogenous cellular 
products associated with tissue injury or self-danger signals (danger associated 
molecular patterns DAMPs), such as toxic compounds, defective nucleic acid or 
presence of normal cell components in atypical extracellular or intracellular locations 
(reviewed by Schroder and Tschopp, 2010).  
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1.6. Cytokines in Inflammation: Biology of Interleukin1  
 
Cytokines are a group of signalling proteins produced transiently, like a self-limited 
event, after activation of several different cell types that act as humoral regulators in 
a locally autocrine or paracrine manner. The name cytokine derives from Greek kytos 
that means “vessel” and kinein that means “to move”. Among the cytokines, IL-1 β is 
considered a major orchestrator of inflammatory and immune response for its well 
known pleiotropic activities. IL-1β belongs to IL-1 family ligands, together with 
interleukin 1 alpha (IL-1α), naturally occurring competitive IL-1-receptor antagonist 
(IL-1RA) and other seven members (Garlanda et al., 2013). IL-1 was the first 
interleukin to be identified as endogenous pyrogen for its ability to produce fever. 
Later studies demonstrated that IL-1 endogenous pyrogen did more than cause fever. 
It was recognized as lymphocyte-activating factor, hemopoietin-1, and osteoclast-
activating factor, catabolin, until the final terminology of IL- 1, that now includes  all 
previously described properties. IL-1 consists of two separate ligands, IL-1α and IL-
1β (Dinarello, 1996). These proteins have high sequence homology, despite being the 
product of different genes. They are synthesized as large precursor proteins of 31 
KDa. Pro-IL-1α is biologically active and it is cleaved by calpain to generate the 
smaller mature protein. By contrast, IL-1β is produced in the form of biological 
inactive pro-cytokine in the cytosol. IL-1β exerts its biological effects by binding the 
membrane-bound type I IL-1 receptor (IL-1R1). The receptor contains extracellular 
immunoglobulin domains and a Toll/IL-1 receptor (TIR) domain in the cytoplasmic 
portion. Binding of the ligand allows the recruitment of a second receptor subunit, 
the IL-1R accessory protein (IL-1RacP or IL-1R3) to form a complex that activates 
intracellular signalling. The receptor heterodimer complex induces signalling 
because the juxtaposition of the two TIR domains enables the recruitment of Myd88, 
IL-1R associated kinase 4 (IRAK4), TNFR-associated factor 6 (TRAF6) and other 
signalling intermediates. The ensuing biological response typically involves the 
activation of the nuclear factor-κB (NF-κB) and mitogen-activated protein kinase 
(MAPK) pathways that lead to the induction of a large number of pro-inflammatory 
and immune genes. IL-1R1 can bind the agonist cytokine IL-1β and also IL-1α, both 
with high affinity (0.1–1.0 nM), and the IL-1Ra with comparable efficiency. 
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However, the contact mode between IL-1Ra and IL-1R1 only induces a partial 
wrapping of the receptor around IL-1Ra, with the receptor structure being more 
extended and open than the one of the IL-1β–IL-1R1complex. There is also a second 
receptor for IL-1, called type II IL-1 receptor (IL-1R2), with an extracellular domain 
highly homologous to that of IL-1R1 and being able to bind IL-1β, but unable to 
initiate signalling because of its very short cytoplasmic portion lacking the TIR 
domain (reviewed by Boraschi and Tagliabue, 2013). IL-1R2 can perform its role 
either on the cell surface or as soluble receptor after it is detached from the plasma 
membrane, acting as molecular trap for IL-1 and functioning as a negative regulator. 
Thus, IL-1R2 is considered a decoy receptor because of its capability to recognize 
the ligands with high affinity and specificity, although its structure is not able to 
activate intracellular signalling. IL-1R2 and IL-1Ra, a polypeptide antagonist, exert a 
tight control of the IL-1 signalling system during potentially devastating local and 
systemic inflammatory reactions (Figure 1.4C). 
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1.7. Activation of IL-1β  
 
Many stimuli can activate the synthesis of the inactive form of IL-1β, including 
bacterial lipopolysaccharides (LPS), microbial products, cytokines and immune 
complex. However, a second step is required to produce the active protein. The 
processing enzyme that cleaves the inactive IL-1β into mature protein is a cystein 
protease, called IL-1β converting enzyme (ICE or caspase-1). This caspase, like 
other caspases, is present in the cells as catalytically inactive zymogen and generally 
undergoes proteolytic processing during activation (Martinon and Tschopp, 2007). 
The best-studied models for caspase-1 activation are linked to the stimulation of 
NOD-like receptor 3, NLRP3. This receptor, like other NLRs, is able to recognize a 
range of compounds that are indicative of injury, including extracellular ATP, 
metabolic stressors, such as elevated levels of glucose and monosodium urate 
crystals, environmental irritants, as UVB irradiation. Upon NLRP3 activation, its 
oligomerization leads to the activation of the adaptor protein ASC that in turn binds 
the recruit domain CARD of procaspase-1. The effect of this binding is the auto-
cleavage and formation of the active caspase-1 (reviewed by Schroder and Tschopp, 
2010) (Figure 1.4A).  
 
Since the IL-1β protein lacks a conventional signal peptide, the precise mechanisms 
of protein secretion are not well known. Typically, proteins are cotranslationally 
translocated into the endoplasmic reticulum (ER), although some are 
posttranslationally translocated. The presence of a signal sequence at the N-terminus 
of the nascent peptide is the first step for its translocation into the ER lumen. Here, 
the signal peptide is removed and, with the aid of chaperones, assumes a correctly 
folded state. A complex of proteins facilitate its passage into the Golgi, where it can 
receive further posttranslational modifications before its packaging and transport to 
the final destination, that can be another organelle or exocytosis.  
 
This idea arose from different studies in which the routes of secretion employed are 
dictated by the strength of the inflammatory stimulus and by the extracellular levels 
of IL-1β required to mount an effective inflammatory response. Three categories of 
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secretion mechanisms have been proposed (reviewed by Lopez-Castejon and 
Brough, 2011) (Figure 1.4B).  
 
 
 
 
 
Figure 1.4. IL-1β signalling. A. Mechanisms of activation of inflammasome and active IL-
1β production. B. Different routes of Il-1β secretion. C. IL-1 receptor complexes (adapted 
from, respectively, Schroder and Tschopp, 2010; Lopez-Castejon and Brough, 2011; 
Boraschi and Tagliabue, 2013).    
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1.8. IL-1β in Adult Seizure and Epilepsy Models  
 
The inflammatory responses associated to seizure induction have been discussed for 
long time. Several studies suggest that inflammatory mediators and glial cells are 
important contributors in the process of epilepsy, with particular regard to IL-1β. 
First, this cytokine may be released in the brain after seizure induction in some 
rodent models organism (Plata-Salamàn et al., 2000; Minami et al., 1990; Vezzani et 
al., 1999; Vezzani et al., 2002; Eriksson et al., 2000; Viviani et al., 2003; Steffensen 
et al., 1994; Zhu et al., 2006). Second, clinical evidence from human studies suggests 
that IL-1β gene polymorphism is associated with an increased susceptibility to 
seizures and epilepsy (Kanemoto et al., 2003). These findings define a distinct pro-
epileptogenic role for IL-1β (Vezzani et al., 2007). During the process of 
epileptogenesis, regardless of whether neuronal cell death take place or not, IL-1β 
promotes the activation of classical signalling pathways that involve the 
transcriptional responses mediated by MAPK and NF-kB, and a non-conventional 
rapid effect on neuronal transcription that involved change in ion channels and 
neurotransmitter receptors (Figure 1.5).  
 
Beyond these experimental evidences, it has also suggested an anti-convulsant effect 
of IL-1β in seizure generation. The study of IL-1β and IL1R1 null adult mice treated 
with two different proconvulsants (PTZ and KA) has shown an increased seizure 
severity and duration (Claycob et al., 2012). Retrospectively, in vitro studies support 
this recent finding, suggesting that IL-1β can act in potentiating the GABAergic 
transmission and by reducing the hyperexcitability of the brain (Zhu et al., 2006). 
Thus, the effects of IL-1β on the excitability of neurons could depend on many 
factors, such as the IL-1β concentration in the brain, the functional state and the type 
of neurons involved in the seizure, and the neuronal exposure time to this cytokine.  
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Figure 1.5.  Il-1β involvement in epileptogenesis processes (Vezzani et al., 2007). 
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1.9. IL-1β vs Seizure and Epilepsy in the Immature Brain  
 
During the first months of life, children are exposed to a particularly high risk for 
seizures, because of varying injuries can occurs such as birth trauma, infections, 
intracranial haemorrhages, and metabolic disturbances (Holmes and Ben-Ari, 2001). 
Moreover, fever rarely results in seizures in adults while it causes “febrile” seizures 
in 3-5% of infants and children in the Western world (with peaks up to 14% in 
Japan) and constitute the most common seizure type in the developing brain (Hauser, 
1994). All together, immature brain is clearly more prone to seizures: this feature is 
directly linked to the developing context. During development, excitatory and 
inhibitory receptors are not expressed simultaneously and their functionality is 
different with respect to the mature brain. In neonate, it has been demonstrated that 
GABA receptors have depolarizing properties (reviewed by Holmes and Ben-Ari, 
2001). Although in children most seizures are benign and do not evolve into epilepsy 
later in life, experimental studies using animal models suggest that frequent or 
prolonged seizures in the developing brain can generate long-lasting effects (Ben-Ari 
and Holmes, 2006). Seizure may, in fact, perturb the developing neurons and affect 
the proliferation and migration and the establishment of new synapses, a process that 
is essential for the correct formation and wiring of the brain network and circuitry. 
For this reason, animal models of seizures in the immature brain provide a unique 
opportunity to study the enhanced excitability during development. 
  
Rats are commonly used as animal organism in epilepsy research focusing on the 
developing brain. Rats are born in a premature state relative to human: a 8–10 day 
old, postnatal (P) rat corresponds to a full-term neonate, a P12–18 rat to an 
infant/toddler, and a P25–38 rat to a peripubertal child (Haut et al., 2004; reviewed 
by Holopain, 2008). Mechanisms linked to cell death in the mature brain, such as the 
inflammatory reactions, do not seem to affect the young rat brain. Rizzi et collegues 
(2003) demonstrated that the activation of glia and related production of cytokines is 
age-dependent. Ravizza et collegues (2005) have proposed weak microglia activation 
in the hippocampus of P9 rats, whereas strongly immunoreactive microglia cells 
appeared not only in the hippocampus but also in the extrahippocampal areas in older 
 19 
 
rats (P15 and P21). Moreover, the expression of GFAP and interleukin IL-1β 
mRNAs does not increase in P9, is upregulated in P15, and is extensively augmented 
in P21 along with the expression of all the cytokines studied, i.e. interleukin-6 (IL-6) 
and Tumor Necrosis Factor alpha (TNFα), with the appearance of degenerating 
neurons. Age-dependent activation and expression levels of cytokines, and glial 
reactivity, have been recently confirmed (Javela et al., 2011). The proposed 
mechanism consists in a rapid expression of inflammatory cytokines, followed by an 
activation of glial cells in a subacute phase that follows seizure induction in the 
juvenile brain (P15). In the immature brain (P9), on the contrary, the expression of 
IL-1β is increased after 24 hour of seizure induction, with no morphological changes 
in the resting states of microglia. The transient increase of cytokine mRNA 
expression, and the persistence of glial cell reaction at the subacute phase, suggests 
the existence of a fulminant and general initial reaction towards a more moderate and 
precisely targeted response (Javela et al., 2011). 
 
Studies in animal models have made important contributions in the understanding of 
the effects of seizures and in the identification of related long-term consequences for 
behavioural and cognitive processes in the epileptic brain. A better comprehension of 
seizure events “from genes to behaviour” relies on the precise definition of the 
different levels of time-dependent changes (Holopain, 2008). Indeed, we still know 
little not only about the entire temporal dynamics of the seizure event in itself, but 
we also need to gain deeper insights on the relationship between seizures and the 
specific ontogenetic window in which they occur. To this aim, the use of a simple 
vertebrate model organism may offer the opportunity to dissect the complex 
molecular and cellular events associated with seizure and epilepsy. In particular, 
emerging model systems such as the zebrafish may be also instrumentals to the 
exploration of the degree of phylogenetic conservation of the seizure-related 
mechanisms.  
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1.10. The Zebrafish Model 
 
Zebrafish (Danio rerio), a small tropical fish native to Southeast Asia, is now a well-
established model organism in biomedical research, because of its characteristics that 
make it very versatile. Its multiple advantages include small size, the limited dietary 
requirement and a short generation that allow keeping many fishes in a confined 
space, with low cost- and space-effectiveness. The great proliferative capacity and 
the number of progeny (up to 200 embryos per reproductive event) guarantee a huge 
amount of experimental units within a year. Thanks to the transparency of zebrafish 
embryo and larvae, including optical access to the central nervous system (CNS), and 
to the external fertilization, it is possible (i) to observe all stages of embryonic 
development, (ii) to follow the different cellular fates and (iii) to monitor at each 
stage the expression of specific genes. Embryonic development is rapid so that it is 
possible to observe distinct morphological characteristics 24 hours post fertilization 
(hpf) (Kimmel et al., 1995) (Figure 1.6).  
 
 
 
Figure 1.6.  Zebrafish developmental stages. A-E The animal pole is to the top for the 
early stages, (F) anterior is up or (G-L) to the left at later stages (Kimmel et al., 1995). 
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Other advantages include the ability to easily manipulate eggs and embryos, allowing 
transplantation, cell ablation or microinjection of nucleic acids (e.g. Morpholino 
antisense oligonucleotides and mRNA) to achieve gene knockdown or gain-of 
function. Finally, zebrafish possess high physiological and genetic homology to 
mammals (Howe et al., 2013). Both larval and adult zebrafish are extensively used in 
neurobiology research also to model and address various brain disorders. 
Specifically, zebrafish offer the potential for brain imaging, behavioural phenomics 
and high-throughput screening (HTS). This model organism is also critical for drug 
discovery and for identifying novel candidate genes implicated in brain disorders, 
ranging from neoplastic to neurological and neuropsychiatric illnesses (Stewart et al., 
2014) (Figure 1.7). Taken together, these evidences indicate that Danio rerio is one 
of the main organisms in translational neuroscience research, complementing both 
rodent and clinical models of major brain disorders. In fact, also epilepsy, commonly 
studied in rodents, can be modelled in zebrafish. In this regard, Baraban and 
colleagues examined for the first time in 2005 the feasibility of using developing 
zebrafish larvae as an epilepsy model system. They hypothesized that zebrafish 
larvae at 7 dpf has developed the brain structures that are implicated in the 
development of complex seizure activity. These authors demonstrated the general 
usefulness of the zebrafish model, describing changes in behavioural, 
electrophysiological and c-fos gene expression, the latter being typically elevated 
during seizures in rodents (Baraban et al., 2005). Subsequently, other scientists have 
used adult zebrafish to model seizures (Mussulini et al., 2013), as well as larvae to 
test the action of several anti-convulsant agents. These approaches permitted to 
define zebrafish as a powerful HTS model for testing various pro- and anti-epileptic 
drugs (Baxendale et al., 2012). Moreover, targeted mutations in zebrafish 
orthologues of known genes that cause epilepsy in humans and rodents are being 
produced. One example is the mind-bomb mutant, in which alterations of E3 
ubiquitin ligase activity and of Notch signalling result in defects in brain 
development and in spontaneous seizures (Hortopan et al., 2010). Another example 
is the mutation in the zebrafish orthologue of SCN1A, a gene that encodes a voltage-
gated sodium channel. In humans, mutations in this gene cause characteristic Dravet 
syndrome with severe intellectual disability and drug-resistant seizures. At the same 
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time, scn1Lab
-/-
 mutant zebrafish display a spontaneous seizure-like activity, 
supporting the use of zebrafish for modelling also pediatric epilepsy (Baraban et al., 
2013).  
 
As for neuronal activity studies, zebrafish offers many advantages as model for 
analyzing immune responses associated with human diseases. The zebrafish immune 
system presents similarities with that of humans, with comparable immune cell types 
and signalling pathways associated to pathogen infections as well as to mechanical 
and chemical injuries (Nguyen-Chi et al., 2014; Ogryzko et al., 2014; van Ham et al., 
2014). Already one day post fertilization, zebrafish embryos present functional 
macrophages that are capable of sensing and responding to pathogens. At 2 dpf, the 
capability to combat infections is increased in concomitance with the appearance of 
differentiated neutrophils. Both macrophages and neutrophils are able to migrate 
rapidly to sites of infections or wound-induced inflammation (Figure 1.8B). Between 
2 and 3 dpf, primitive macrophages colonize the brain and retina and became early 
microglia cells, thus starting to express high levels of apolipoprotein-E, with the 
concomitant downregulation of l-plastin, a common marker of leucocytes (Figure 
1.8A) (Meijer and Spaink, 2011). Not only almost all cell types of the mammalian 
immune system have been identified in zebrafish, but also the receptors signalling 
molecules and pathways have their fish orthologue counterparts. For example, the 
TLR genes are expressed during all stages of embryonic development (van der Sar et 
al., 2006), and also the NLR family has a number of orthologues in all fish species 
(Angosto and Mulero, 2014; Ogryzko et al., 2014). Among the latter family, NALP3 
responds to various stimuli by forming the inflammasome complex that promotes the 
release of IL-1β (Angosto and Mulero, 2014). 
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Figure 1.7. Representative advantages in zebrafish biomedical research (modified from 
Stewart et al., 2013). 
 
 
 
With respect to IL-1 biology, early studies in zebrafish had highlighted important 
differences with respect to the mammalian orthologous gene, including human, such 
as the lack of a conserved caspase-1 cleavage site in the zebrafish homologue and an 
amino acid identity of only 27%. However, it was later shown that the C-terminal 
domain of the mature protein has higher identity with mammals. In fact, the Phyre 
structural predition server allowed to identify the presence of a β-sheet rich trefoil 
structure in zebrafish IL-1β sequence that closely matches with the mature human 
protein (Ogryzko et al., 2014) (Figure 1.9A-B). In addition, the presence of two 
inflammatory caspases in zebrafish has been reported. These zebrafish inflammatory 
caspases are able to process IL-1β in vitro by using different amino acid residues 
with respect to the mammalian gene (Figure 1.9C), and are sensitive to mammalian 
caspase-1 inhibitors in vivo (Vojtech et al., 2012; Ogryzko et al., 2014). Together 
with the increasing evidence of evolutionary and functional aspects in the zebrafish 
C D 
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inflammasome, the power of zebrafish as model to study the IL-1β inflammatory 
pathways is well established.  
 
 
 
Figure 1.8. Zebrafish Immunity. A. Schematic representation of zebrafish immunity 
development (Meijer and Spain, 2011). B. Examples of zebrafish model of inflammatory 
response (Chi et al., 2014; Ogryzko et al., 2014; van Ham et al., 2014).  
 
 
A 
B 
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Figure 1.9. IL-1β protein. A. Representation of Human IL-1β. B. Representation of 
zebrafish IL-1β. C. Cut site of zebrafish caspase-1 orthologues (Ogryzko et al., 2014.)  
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1.11. Aims of the Project 
 
The aims of my PhD project are to characterize seizures and seizure-related effects in 
an early phase of functional maturation of zebrafish brain by using PTZ. Current 
literature demonstrated that PTZ administration induces seizures in zebrafish larvae 
and adults, associated with alteration in locomotory responses and changes in 
expression of c-fos gene, a marker of neuronal hyperactivity (Baraban et al., 2005; 
Mussulini et al., 2013). Recently, Baxedale and collegues (2012) have investigated 
the possibility in developing seizures also in the early phase of zebrafish 
development (2 dpf), showing that GABA components are still expressed in the 
embryonic zebrafish brain and, like c-fos, other genes are regulated by PTZ-induced 
seizures, one of which is bdnf. Until now, PTZ model of seizure has been used for 
studying the activation of epilepsy mechanisms and for anti-epileptic drugs 
discovery. Therefore, we still know little about the temporal regulation of seizures in 
the PTZ zebrafish model during the entire event from induction to recovery. Starting 
from the evidence that PTZ can promote seizures in 3 dpf zebrafish larval brain, the 
first objective of my PhD project is to characterize the locomotory phenotype and the 
transcriptional responses associated with the hyperexcitability condition. The second 
objective is to analyse the transcriptional and cellular mechanisms of inflammation 
involved in PTZ-induced seizures in zebrafish and to verify to which extent 
inflammatory responses are eventually responsible for the seizure event itself. 
 
In this PhD project, I will address the following questions in the immature brain of 
zebrafish larvae: 
 
 Which is the temporal regulation of hyperexcitation after seizures? 
 Are acute seizures able to activate an inflammatory response? 
 Do inflammatory molecules contribute to seizure chronicization? 
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CHAPTER 2 
 
Material and Methods 
 
2.1. Zebrafish (Danio rerio) care 
 
Adult zebrafish are kept in a Tecniplast Stand alone unit (Italy) under standard 
controlled conditions: 28°C, 400 μS and pH 7.5. The lighting is kept on daily cycle 
of 14  hours of light and10 hours of dark to the fish to breed.  Embryos were staged 
according to hours post fertilization (hpf) and morphological criteria (Kimmel et al., 
1995). To perform experiments, embryos were manually dechorionated and 
anaesthetized in tricaine before fixed overnight, using 4% Paraformaldehyde (PFA) 
in PBS. Then, they were washed in PBT (PBS + 0.1% Tween-20), dehydrated and 
stored in methanol at -20°C. 
 
 
2.2. RNA extraction and RNA quality detection 
 
Anaesthetized control and treated 3 dpf zebrafish larvae (n=15) were collected in 500 
μl TRIZOL reagent (Invitrogen), and frozen at -80°C until RNA extraction. The 
tissue was homogenized using Tissue Lyser for 5 minutes at 25 Hertz (Hz). After the 
homogenisation, the samples were incubated at room temperature (R.T.) for 5 
minutes and then placed on ice while the other samples were processed. When the 5 
minute incubation period of the last sample was completed, 100 μl of chloroform 
(Sigma) were added to the homogenates. Samples were vortexed and incubated at 
R.T. for 3 minutes. After this short incubation, they were centrifuged at 12000 rpm at 
4°C for 15 minutes. The aqueous phase was transferred into a clean tube and the 
RNA precipitated with 200 μl phenol –chloroform and centrifuged at 12000 rpm at 
4°C for 15 minutes. After then, the RNA were precipitated using 2 volume of 
isopropanol, 1/10 volumes of acetic sodium 3 M pH 5.2, 1 μl of glycogen and 
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transferred at -20°C for 30 minutes. The tubes were centrifuged for 5 minutes at 
13500 rpm, the supernatant was discarded and the pellets were washed in 70% 
ethanol in DEPC treated water by centrifuging the samples for 5 minutes at 10000 
rpm. The supernatant was once again discarded and the pellets were left to air dry, 
then dissolved in 30 μl DEPC and stored at -80°C. 
 
RNA was analyzed by the 2100 ByoAnalyser machine (Agilent Tecnologies) using 
the Eukaryote total RNA Nano Series assay. The integrity of RNA was estimated by 
RNA Integrity Number (RIN) values, calculated by an algorithm that assigns a 1 to 
10 RIN score, where level 10 RNA is completely intact value (Figure 2.1).  
 
 
 
 
Figure 2.1. RNA quality assay. The right panel shows the electrophoresis gel image of the 
ladder (first lane) and of 6 RNA samples (samples 1-6) prepared from control and treated 
larvae. The right panel shows the electropherogram profile summary of the RNA samples (1-
6).  
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2.3. Reverse Transcription   
 
First strand cDNA synthesis from total RNA was obtained by SuperScript VILO™ 
MasterMix Kit (Invitrogen). This SuperScript® VILO™ Master Mix kit includes 
SuperScript® III RT, RNaseOUT™ Recombinant Ribonuclease Inhibitor, a 
proprietary helper protein, random primers, MgCl2, and dNTPs. 1 μg of total RNA 
was added to 4 μl of  SuperScript® VILO™ Master Mix and RNase-free H2O to 
obtain a final volume of 20 μl. The reaction mix was incubated at 25°C for 10 
minutes, then, at 42°C for 60 minutes and finally stopped by heating at 85°C for 5 
minutes. The cDNA was stored at –20°C. 
 
 
2.4. PCR amplification 
 
The PCR reactions have been performed in a total volume of 50 μl, using cDNA as 
template, 0.2 mM of dNTP mix (dATP, dTTP, dCTP, dGTP), 1x PCR buffer 
(Roche), 0.05 U/μl of Taq DNA polymerase (Roche) and forward and reverse 
suitable oligonucleotides. The PCR amplification program has been set as follows: 
 
 
 First step (1 cycle). DNA denaturation: 5 minutes at 95°C. 
 Second step (repeated for 35 cycles). 
DNA denaturation: 1 minute at 95°C. 
Oligonucleotide annealing: 1 minute at suitable temperature (the temperature 
used in this step has been set at least 5-8°C below the melting temperature of 
the oligonucleotides (Table 1 and 2)). 
Polymerization: 72°C for a suitable time, calculated considering the desired 
amplified fragment length and the Taq DNA Polymerase processivity, that is 
around 1 Kb/minute. 
 Final elongation step: 10 minutes at 72°C. 
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In order to separate the amplified fragments from the template and from dNTPs and 
oligonucleotides excess, gel electrophoresis have been performed using, as fragment 
length marker, 1x GeneRuler™ 1Kb DNA Ladder (Fermentas), according to the 
expected length of the fragment. 
 
 
2.5. DNA gel electrophoresis 
 
Preparative and analytic DNA gel electrophoresis has been performed on 1% of 
agarose gel in 1x TAE buffer (TAE Stock solution 50x: 252 g of Tris base; 57.1 ml 
glacial acetic acid; 100 ml 0.5 M EDTA; H20 to 1 liter) and adding 0.5 μg/ml of 
Ethidium Bromide (EtBr).  
 
 
2.6. DNA gel extraction 
 
PCR amplified fragments have been extracted from gel cutting them with a sterile 
sharpen blade, using the GenElute™ Gel Extraction Kit (Sigma-Aldrich), following 
the manufacturer’s instructions. After the extraction, the concentration has been 
estimated by gel electrophoresis. 
 
 
 
2.7. TOPO cloning 
 
PCR amplifications were performed on cDNAs at 3 dpf. The amplicons obtained 
were cloned in the pCR®II vector (TOPO® TA Cloning Dual Promoter Kit, 
Invitrogen), following the manufacturer‘s indications.  
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2.8. Bacterial cell electroporation 
 
This approach allows transforming bacterial cells with plasmids containing DNA of 
interest. Briefly, the circular plasmid DNA and competent E. coli bacterial cells 
(prepared by the Molecular Biology Service of the Stazione Zoologica Anton Dohrn 
of Naples), were placed in a 0.2 cm electrocuvette. The electrocuvette was subjected 
to an electric pulse at constant 1.7 V using a Bio-Rad Gene Pulser™ electroporation 
apparatus.  
The transformed E. coli cells were allowed to recover for one hour at 37ºC in 1ml LB 
medium (NaCl 10 g/l, bactotryptone 10 g/l, yeast extract 5 g/l,). An aliquot was 
spread on a pre-warmed LB solid medium (NaCl 10 g/l, bactotryptone 10 g/l, yeast 
extract 5 g/l, agar 15 g/l) in the presence of specific selective antibiotic and let grow 
at the same temperature overnight. 
 
 
2.9. Plasmid DNA Mini-Preparation 
 
A single bacterial colony containing the plasmid DNA of interest was grown in a 
suitable volume of LB (4-5 ml) in the presence of the appropriate antibiotic and 
shaking at 37°C overnight. The Sigma-Aldrich Plasmid Purification kit, based on 
alkaline lyses method, was used to isolate the plasmid DNA from the cells according 
to the manufacture‘s instruction. 
 
 
2.10. Sequencing 
 
The DNA sequences have been obtained using the Automated Capillary 
Electrophoresis Sequencer 3730 DNA Analyzer (Applied Biosystems, Foster City, 
CA) by the Molecular Biology Service of the Stazione Zoologica Anton Dohrn of 
Naples. 
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2.11. DNA digestion with restriction endonucleases 
 
Analytic and preparative plasmid DNA digestions have been performed with the 
appropriate restriction endonucleases in total volumes of at least 20 times more than 
the enzyme volume used. The digestion reaction has been prepared as follows: the 
solution contained the desired amount of DNA, suitable restriction enzyme buffer 
(1/10, New England Biolabs), restriction enzyme (5 units enzyme per 1 μg of DNA) 
and BSA (1/100, if required). Reaction specific temperatures have been used as 
suggested by manufacturer’s instructions. 
 
 
2.12. Digested plasmid purification 
 
In order to eliminate protein contaminations and to obtain the template for riboprobe 
synthesis, the plasmid DNA linearized has been purified with 1 volume of 
phenol:chloroform:isoamylic alcohol (25:24:1), vortexed vigorously and centrifuged 
at 13000 rpm for 5 minutes at 4°C. The soluble phase has been recovered and 1 
volume of chloroform:isoamylic alcohol (24:1) has been added; the sample has been 
vortexed vigorously and centrifuged at 13000 rpm for 5 minutes, at 4°C. The 
aqueous phase has been recovered and the DNA has been precipitated adding 2.2 
volumes of ethanol 95%, 1/10 volume of Sodium Acetate 3 M pH 5.2 and 1 µl of 
glycogen. The sample has been mixed and stored over night at -20°C or 1 hour at -
80°C. Then, it has been centrifuged at 13000 rpm for 15 minutes, at 4°C. The 
precipitated DNA has been washed with ethanol 70% (sterile or DEPC-treated), 
centrifuging at 13000 rpm for 15 minutes at 4°C. The ethanol has been removed and 
the sample has been air-dried at R.T. At the end, the DNA has been diluted in a 
suitable volume of H2O (sterile or DEPC-treated). Its concentration has been 
evaluated by gel electrophoresis, using a spectrophotometer (Nanodrop 1000, 
Thermo SCIENTIFIC). To ascertain the absence of chemical (phenol, ethanol) and 
protein contamination, the values at the wavelengths of 230, 260 and 280 nm have 
been read and the ratio between 260/230 nm and 260/280 nm has been calculated. 
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2.13. Ribonucleic probe preparation 
 
The in vitro transcription was performed using the DIG RNA labeling kit (Roche). 1 
μg of purified and linearized DNA has been used as template for the ribonucleic 
probe synthesis. This template has been added to the following reaction mix: 
transcription buffer (10X 2 μl); Digoxigenin mix, containing 1 mM of ATP, CTP and 
GTP, 0.65 mM UTP and 0.35 mM DIG-11-UTP (10X 2 μl); Sp6 or T7 RNA 
polymerase (20 U/μl); Protector RNase inhibitor (20 U/μl), in H2O DEPC-treated. 
The mix has been briefly centrifuged and incubated for 2 hours at 37°C. Then, 
DNaseI RNase free has been added in order to remove the DNA template. The 
sample has been incubated for 20 minutes at 37°C. Finally, the reaction has been 
stopped adding 0.2 M EDTA pH 8.0. The RNA riboprobes have been precipitated by 
adding LiCl (4 M) and ice cold 100% ethanol at -20°C, and then centrifugated at 
4°C. The pellet has been washed with ice cold 70% ethanol and allowed to air-dry. 
The probes has been dissolved in DEPC water. The ribonucleic probe quality has 
been checked by gel electrophoresis. Recovered samples have been immediately 
stored at -80°C until the use.  
 
 
2.14. Whole mount in situ hybridization   
 
Day 1: embryos were rehydrated stepwise in methanol ⁄ PBS and finally put back in 
PBT. Samples were incubated in proteinase K (10 μg/ml in PBT) for a period of 30 
minutes for 3 dpf embryos. Reactions were stopped by rinsing in PBT followed by 
post-fixation in 4% paraformaldehyde in 1x PBS for 20 minutes at R.T. and by 
rinsing four times in PBT (5 minutes).  Zebrafish embryos were pre-hybridized for at 
least 1 hour at 65°C in hybridization buffer (50% formamide, 1.3x SSC, 5 mM 
EDTA (pH 8.0), 50 µg/ml yeast RNA, 0.2% Tween 20, 0.5% CHAPS 10%, 100 
µg/ml heparin). Embryos were then incubated overnight in the hybridization solution 
containing the probe at 65 °C (probe was denatured for 10 minutes at 95 °C).  
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Day 2: probe was removed by 30 minutes step - wise washes in 100, 75, 50 and 25% 
hybridization buffer and 2x SSC for 5 minutes, in 2x SSC for 10 minutes, in 0.2x 
SSC for 30 minutes, in 10 mM PIPES and 0.5 M NaCl  for 10 minutes, and finally in 
Maleic Buffer Tween - 20 (MBT). Subsequently, embryos were incubated in 2% 
Roche Blocking Reagent (Roche Applied Science, code 11 096 176 001) for 2 hours 
and then left in Fab - alkaline phosphatase (Roche Applied Science, code 11 093 274 
910) at a 5000 - fold dilution in fresh MBT plus blocking reagents overnight at 4 °C. 
 
Day 3: After several washes in MBT, embryos were incubated in a staining buffer 
(100 ml NaCl 5 M; 100 ml Tris HCl 1 M, pH 9.5; 50 ml MgCl2 1 M; 0.1% Tween - 
20) and then in BM Purple (Roche Applied Science), a chromogenic substrate for 
alkaline phosphatase until staining was sufficiently developed. After stopping the 
reaction, embryos were post-fixed in 4% paraformaldehyde in 1x PBS for 20 minutes 
and finally stored in 95% glycerol at 4°C.  Embryos were imaged using a Zeiss Axio 
Imager M1 microscope equipped with Axiocam digital camera (Zeiss). WISH 
experiments were performed in triplicate.  
 
 
2.15. Double Immunofluorescence analysis 
 
Day 1. 3 dpf larvae kept in MeOH at -20°C, were rehydrated through a 10 minutes 
wash in 50:50 MeOH:PBS and then washed 3 times for 5 minutes in PBTr (PBS + 
0.01% Triton-100). The larvae were incubated in PBTr containing 10 μg/ml 
proteinase K for 45 minutes at R.T. Following the proteinase K treatment, the 
samples were washed 3 more times for 5 minutes with PBtr. Samples were fixed in 
fish fix for 20 minutes at R.T. and then incubated in PBS-Block (4% Normal goat 
serum, 1% BSA, 1%DMSO, 0.1% Tween and 0.01% Triton) for at least 1 hours. The 
larvae were left overnight in PBS-Block (1% NGS, 1% BSA, 0.5% DMSO, 0.1% 
Tween-20 and 0.1% Triton-100) containing primary antibodies (1:300, GFAP Dako, 
1:300 GS Millipore) at 4°C and 1:10000 Topro3 (Life Technologies). 
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Day 2. The samples were washed for 30 minutes at R.T. with PBSTT (0.1% Tween-
20 and 0.1% Triton-100). Then the PBSTT was replaced with PBSTT with anti-
rabbit and anti-mouse Alexa Fluor coniugates (Invitrogen). 
 
Day 3. The samples were washed 5 times at R.T. for 30 minutes with PBSTT and 
then mounted in glycerol 75% for confocal microscope analysis, using the two-
photon confocal SP8X Leica. 
 
 
2.16. Microinjection of morpholino oligos into fertilized eggs  
 
The morpholinos are antisense oligonucleotides with a variable length between 18 
and 25 nucleotide bases that are complementary to the sequence of the gene of 
interest. Their main function is to block mRNA translation and hence protein 
synthesis. In these oligonucleotides, the deoxyribose is replaced by a ring N-
morpholino that gives great stability. In my case, I have used a morpholino for the 
knockdown the IL-1β gene that had been tested and validated in previous studies. 
The oligonucleotide sequence is supplied as a liophilized product from Gene Tools, 
LLC:  
 IL-1β ssMO: 5’-CCCACAAACTGCAAAATATCAGCTT - 3’  
The entire instrumental setting is composed of a stereomicroscope Zeiss, a 
micromanipulator MN of Narishige and a Picospritzer® III of Parker 
Instrumentation. The fertilized eggs were collected, cleaned and oriented with the 
animal pole into the capillary. The needles used for the microinjection were made 
from tubes capillaries (Microcaps from Drummond Sci. Co., Broomall, PA, USA), 
appropriately drawn with a specific instrument  ―microelectrode puller (Model PN - 
3, Narishige, Tokyo) choosing suitable conditions of pressure and temperature to the 
needs of microinjection. Once needles were prepared, they were filled with a solution 
containing a concentration range of morpholino between 8 µg/µl and 0.1 µg/µl in 
sterile water, 0.5 % of phenol red (Sigma) as marker, and used for microinjection 
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into fertilized eggs. The volume injected was calculated measuring the diameter of 
drop through micrometre under the microscope and, using the formula of sphere 
volume (4/3π r3).  In order to identify potential endogenous and non-specific effects 
of morpholino oligonucleotides, as a negative control, a standard control morpholino 
was injected. In particular, a standard control morpholino from Gene Tools, directed 
against human β-globin pre-mRNA has been used. The experiments were repeated 
several times.    
 
 
2.17. Quantitative Real-time PCR  
 
The quantitative PCR (qPCR) allows to quantify the nucleic acid of a sample in 
relation to the amount of DNA produced in a PCR reaction, measured evaluating the 
fluorescence of an intercalating DNA dye, which is monitored at each cycle during 
the amplification. During the PCR exponential phase the amount of product increases 
linearly (on a log plot). The number of cycles needed to attain a threshold  
concentration (Ct) of products is measured in order to compare different samples and 
determine which among them contains the higher amount of a specific sequence. A 
qPCR experiment requires a known reference gene as internal control with constant 
expression in all tested samples and whose expression is not changed by the 
treatment under study. The number of cycles needed for the standards to reach a 
specified Ct is used to normalize the Ct for the selected genes. To capture intra-assay 
variability all RT-qPCR reactions have been carried out in triplicate and the average 
Ct value was taken in to account for further calculations. 
 
The dye used was Fast Sybr Green Master Mix (Applied Biosystems), which binds to 
double stranded DNA (dsDNA). SYBR green dye cannot distinguish between the 
amplicon and contamination products from mispairing or primer-dimer artifacts. To 
overcome this, not only DNA synthesis is monitored, but also the melting point of 
the PCR products is measured at the end of the amplification reaction. The melting 
temperature of a DNA double helix depends on its base composition and its length.  
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For each gene, qPCR primers have been designed to generate products of 100-300 
bp, by using online based “Primer 3, v.0.4.0” software (Table 3).  
The efficiency of each pair of primers was calculated according to standard method 
curves using the equation E=10-1/slope. Five serial dilutions have been set up to 
determine the Ct value and the efficiency of reaction of all pairs of primers. Standard 
curves were generated for each oligonucleotides pair using the Ct value versus the 
logarithm of each dilution factor. Diluted cDNA was used as template in a reaction 
containing a final concentration of 0.7 pmol/μl for each primer and 1X Fast SYBR 
Green master mix (total volume of 10 μl). 
 
PCR amplifications have been performed in triplicate in a ViiA7 ABI Applied 
Biosystems thermal cycler, using the following thermal profile: 95°C for 20'', one 
cycle for cDNA denaturation; 95°C for 1'' and 60°C for 20'', 40 cycles for 
amplification; 95°C for 15'', 60°C for 1' and 95°C for 15'', one cycle for melting 
curve analysis, to verify the presence of a single product. Each assay included a no-
template control for each primer pair. For triplicate samples, Ct is calculated as the 
average among the replicates. All samples were normalised to the levels of the 
housekeeping gene β-actin1 and elf1a.  
 
To calculate the effect of PTZ treatment on transcript levels for each target gene, the 
difference between ∆Ct for the control sample and ∆Ct for the experimental sample 
was obtained: i.e., ∆∆Ct = ∆Ct (experimental) - ∆Ct (control), and converted into 
fold change (FD), assuming FD= 2
-∆∆Ct
. 
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2.18. Pharmacological Induction of Seizures and Pharmacological 
Treatment  
 
Pentylenetetrazole (Sigma) was prepared in stock solution of 200 mM and diluted at 
the final concentration of 15 mM in fresh E3 medium. Larvae were exposed to the 
drugs then analysed as required. Z-YVAD-FMK (YVAD) and Z-VAD-FMK (pan-
caspase) (Enzo Life Sciences) were stored at -20°C and utilized at the final 
concentration, as required.   
 
 
2.19. Tracking analysis 
 
The locomotor activity of larvae was recorded using the DanioVision instrument 
(Noldus). AB larvae at 3 dpf, were transferred to a 96-well plate, one larva per well 
in 100 to 150μl E3 medium with 15mM PTZ. Controls containing E3 alone were also 
included. Right after adding compounds into the E3 media, the plate was placed in 
the observation chamber and the locomotor activity was recorded for 45 minutes 
period, using a two different protocols. In both was included a period of 5 minutes, 
the acclimation time, in which the larvae were detected from the instrument. In the 
first protocol, the light was switch on at maximum intensity of 100% for the entire 
recording period (45 minutes). In the second protocol, the light was switch on off 
every 10 minutes (10’ 100% light on-10’ 0% light off). After the recording, the 
analysis data was exported and was utilized for the statistical analysis. The 
experiments were repeated until the number of larvae analysed per treatment was 
equal or higher than 20. 
 
The treatment with YVAD and pan-caspase drugs was performed in 6-well plate in a 
total volume of 3 mL E3 medium. A number of 10-15 larvae was then transferred to 
a 96-well plate and placed in the observation chamber. The locomotory activity was 
analysed as described before.   
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2.20. Statistical Analysis 
 
Data are presented as mean values ± standard error of mean (SEM). Statistical 
analysis was performed using the GraphPad Prism version 6.0 (GraphPad Software, 
CA, USA). In all analyses, significance level was set at p ≤ 0.05. Statistical 
comparisons between two groups were performed using the Mann–Whitney test and 
Student’s t test were used to determine the significant differences in relative 
expression level for the RT-qPCR analyses. Statistical comparisons between three or 
more groups were performed using one-way analysis of variance (ANOVA) with 
Dunnett’s post hoc test. 
 
 
Tab . 1 Oligonucleotides used for TOPO cloning 
Gene Oligonucleotide Sequence (5’-3’) 
c-fos c-fos Forward AGCCCATGATCTCCTCTGTG 
c-fos Reverse CGTCGTTTTCTGGGTAGGTG 
Bdnf Bdnf Forward ATAGTAACGAACAGGATGG 
Bdnf Reverse GCTGTCACCCACTGGCTAAT 
 
Tab . 2 Oligonucleotides used for RT-PCR 
Gene Oligonucleotide Sequence (5’-3’) 
IL-1β ssMO IL-1β ssMO Forward TGCCGGTCTCCTTCCTGA 
IL-1β ssMO Reverse GCAGAGGAACTTAACCAGCT 
 
Tab. 3 Oligonucleotides used for qPCR  
Gene Oligonucleotide Sequence (5’-3’) 
c-fos c-fos Forward AACTGTCACGGCGATCTCTT 
c-fos Reverse TTGGAGGTCTTTGCTCCAGT 
bdnf Bdnf Forward TCGAAGGACGTTGACCTGTATG 
Bdnf Reverse TGGCGGCATCCAGGTAGT 
TNFα TNFa Forward TCGCATTTCACAAGGCAATTT 
TNFa Reverse GGCCTGGTCCTGGTCATCTC 
IL-6 Il-6 Forward TCAACTTCTCCAGCGTGATG 
Il-6 Reverse TCTTTCCCTCTTTTCCTCCTG 
IL-1β IL-1β Forward ATGCGGGCAATATGAAGTCAC 
IL-1β Reverse GGCCAACTCTAACATGCAGG 
gfap gfap Forward ATTCCAGGTCACAGGTCAGG 
gfap Reverse ATTCCAGGTCACAGGTCAGG 
gs gs Forward ACTTCGGTGTGGTAGCTTCA 
gs Reverse CAGTGAGTCGACGAGCATTG 
gad 1 gad 1 Forward AACTCAGGCGATTGTTGCAT 
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gad 1 Reverse TGAGGACATTTCCAGCCTTC 
gabra 1 gabra 1 Forward TCAGGCAGAGCTGGAAGGAT 
gabra 1 Reverse TGCCGTTGTGGAAGAACGT 
elf1α elf1α Forward GTACTTCTCAGGCTGACTGTG 
elf1α Reverse ACGATCAGCTGTTTCACTCC 
βactin-1 βactin-1 Forward GCCAACAGAGAGAAGATGACAC 
βactin-1 Reverse CAGGAAGGAAGGCTGGAAGAG 
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CHAPTER 3 
 
Results 
 
3.1. Temporal Regulation of the Behavioural and Transcriptional 
Responses associated to Neuronal Hyperexcitation. 
 
 
Locomotory analyses 
 
As described in the introduction, Baraban and collegues were the first to use the 
zebrafish as model organism for studying epileptic seizures. In their research, 7 dpf 
zebrafish larvae were treated with 15 mM GABAA receptor antagonist PTZ, and 
seizure induction was validated by recording the swimming behaviour and 
transcription of the c-fos gene and by using electrophysiological analysis to visualize 
the epileptiform-like activity of the brain.  
 
To describe the processes associated to seizure induction at early stage of zebrafish 
brain maturation (3 dpf), I have treated zebrafish larvae with 15 mM PTZ for 45 
minutes. First, the locomotory activity was analysed during the treatment by 
measuring the total distance moved and the mean velocity of both control and treated 
larvae in a condition of continuous light stimuli in a video-recording session using 
the DanioVision instrument (Noldus). The behavioural analysis shows a statistically 
significant increase of the two measured parameters in the locomotory responses in 
the treated larvae (Figure 3.1).  
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Figure 3.1. Treatment of 3 dpf zebrafish larvae with 15 mM PTZ induces measurable 
convulsive movements. Zebrafish larvae were treated with 15 mM PTZ in E3 medium and 
locomotor swimming behaviour was recorded from the time of PTZ administration to the 
medium until 45 minutes after the onset of treatment. Larvae were analysed using a 
continuos light stimulus (100% intensity). The graph shows the distance moved and velocity 
between control and treated zebrafish larvae. Circle and square symbols represent each 
larvae; the error bars indicate the s.e.m. Asterisks mean statistically significant difference, 
calculated using a Mann-Whitney test (p<0.0001)  
 
 
 
Since the basal locomotory activity is very low in 3 dpf zebrafish larvae, the 
locomotory analysis was performed also under a different protocol in which the light 
was switched on-off every 10 minutes. Also in this experimental condition, PTZ 
treated larvae showed a significant alteration in term of distance swam and velocity 
(Figure 3.2A). These results suggest that treatment of 3 dpf embryos with 15 mM 
PTZ elicits a very rapid and robust seizure-like behavioural response, as indicated by 
the locomotory traces that illustrate the first 5 minutes of treatment (Figure 3.2B). 
Based on these results, the locomotory assay clearly is a useful technique to validate 
the convulsive response to PTZ treatment. 
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Figure 3.2.  Effect of a light-driven protocol on the treatment of 3 dpf zebrafish larvae 
with 15 mM PTZ. A. The graph represents the distance moved and the velocity between 
control and PTZ treated zebrafish larvae for a total duration of 45 minutes, from the moment 
of PTZ administration, using a 10’ light on-10’ light off  stimulus. Circle and square symbols 
represent each larvae; the error bars indicate the s.e.m. Asterisks refer to significant 
difference, calculated using a Mann-Whitney test (p<0.0001). B. Locomotory traces 
representing the first 5 minutes of recording.   
 
 
 
In order to define the temporal expression and regulation of the locomotory 
phenotype after PTZ removal, I have performed DanioVision-based analysis at two 
distinct time point, 2h (short-term effect) and 24h (long-term effect) after PTZ 
removal. As shown in Figure 3.3, the total distance moved and the velocity were not 
significant altered 2h as well as 24h after PTZ removal (Figure 3.4).  
 
A 
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Figure 3. 3. The behavioural responses of zebrafish larvae 2h after PTZ treatment. The 
locomotory parameters of treated larvae were similar to control group, using a 10’ light on-
10’ light off  stimulus. The graph represents the comparison of distance moved and velocity 
between control and PTZ treated zebrafish larvae, for a total duration of 45 minutes 
recording. Circle and square symbols represent each larvae; the error bars indicate s.e.m. No 
significant difference, using a Mann-Whitney test (p > 0.05).  
 
 
 
 
 
Figure 3.4. The behavioural responses of zebrafish larvae 24h after PTZ treatment. The 
locomotory activities of treated larvae returned to normal levels 24h after the end of the 
treatment. The graph represents the comparison of distance moved and velocity between 
control and PTZ treated zebrafish larvae, for a total duration of 45 minutes of recording, 
using a 10’ light on-10’ light off  stimulus. Circle and square symbols represent each larvae; 
the error bars indicate s.e.m. No significant difference, using a Mann-Whitney test (p > 
0.05). 
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Transcriptional analyses 
 
To explore the transcriptional responses of genes directly associated to the PTZ 
treatment, including markers of the active state of neurons as well as markers of 
GABA signalling, I have used two different molecular approaches, that is whole 
mount in situ hybridization (WISH) and Real Time quantitative PCR (RT-qPCR).  
 
One of the most studied genes linked to neuronal activity is the transcription factor c-
fos. It is one of the first known “immediate early genes, IEG” that has been identified 
and it represents the prototypical example of activity-dependent neuronal gene 
transcription. The upregulation of c-fos in neurons of the intact brain was observed in 
specific brain regions in response to seizures and to a wide range of physiological 
stimuli (Morgan and Curran, 1987). Several studies have used the induction of the 
activity dependent transcription factor c-fos as a marker of neurons in the active 
state.  
 
In order to characterise the activation of the c-fos gene in response to PTZ at the end 
of the treatment, I have performed a whole mount in situ hybridization (WISH) in 3 
dpf zebrafish larvae. In controls, no expression of c-fos mRNA was detected; on the 
contrary, the transcriptional activity of c-fos did strongly increase in the brain of 
PTZ-treated fish. In particular, c-fos expression was observed in the forebrain, 
including the telencephalic area, diencephalon, tectum and hindbrain. A diffuse 
signal was present in trunk muscles, consistent with the observation of an intense 
locomotory activity of the larvae (Figure 3.5).  
 
Another well-characterized gene that is regulated by the synaptic activity in 
mammalians is BDNF (brain-derived neurotrophic factor). The BDNF gene plays 
important roles in neuronal growth, survival and synaptogenesis (reviewed by Flavell 
& Greenberg, 2008) and has been investigated in other models of epilepsy based on 
the evidence that both BDNF mRNA and protein are upregulated during different 
types of seizures (reviewed by Koyama and Ikegaya, 2005). Previous results have 
demonstrated that bdnf is overexpressed also in the brain of 4 dpf PTZ-treated 
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zebrafish larvae (Baxedale et al., 2012). Using WISH, I have observed the expression 
pattern of bdnf after PTZ treatment in 3 dpf zebrafish larvae. As shown in Figure 3.6, 
the endogenous expression of bdnf in control larvae is localized in a small region of 
the zebrafish brain that includes the diencephalon (De Felice et al., 2014). After 45 
minutes of PTZ treatment, the expression level of bdnf was strongly upregulated 
throughout the brain, with an expansion of the expression pattern that is similar to the 
one found for c-fos. Altogether, 3 dpf zebrafish larvae treated with PTZ showed a 
precise seizure phenotype characterized by robust increase in locomotory activity 
and up-regulation of synaptic-activity regulated genes. 
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Figure 3.5. Expression of c-fos gene after PTZ treatment in 3 dpf zebrafish larvae. Left 
column shows the control larvae and the right, PTZ treated zebrafish larvae. A, A’, B, B’. 
Lateral view of control (A, A’) and treated (B, B’) zebrafish larvae. A’’, B’’. Dorsal view of 
the head of control and treated zebrafish. B, B’, B’’. c-fos up-regulation in the larval brain. 
Te, telencephalon; To, optic tectum; tg, tegmentum; Ce, cerebellum; Di, diencephalon; Rh, 
rhombencephalon; m, muscles. 
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Figure 3.6. Expression of bdnf gene after PTZ treatment in 3 dpf zebrafish larvae. A, B. 
Lateral view of the head of control and treated larvae. WISH analysis shows the increased 
expression of bdnf mRNA in different territories of the treated larvae. Te, telencephalon; To, 
optic tectum; Tg, tegmentum; Hy, hypothalamus; Rh, rhombencephalon.    
 
 
In order to define the temporal expression and regulation of these genes after PTZ 
removal, I have performed WISH analysis at the same time point tested (2 and 24h). 
As shown in Figure 3.7, the expression of c-fos at 2h after PTZ treatment was 
drastically reduced, suggesting that its activity is required only during PTZ 
antagonistic activity. Differently, bdnf expression remained elevated at 2h, and 
returned at basal levels only 24h after PTZ withdrawn (Figure 3.8). This dynamics of 
expression suggest that, unlike for c-fos, the effect of PTZ treatment on bdnf gene 
activity lasts longer.  
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Figure 3.7. Expression of c-fos gene after PTZ removal in 3 dpf zebrafish larvae. A, B. 
Dorsal view of the head of control and treated larvae. WISH analysis showed that c-fos 
expression in treated larvae is similar to control after 2h post treatment. 
 
 
 
 
Figure 3.8 bdnf gene expression after PTZ removal in 3 dpf zebrafish larvae. The panel 
shows the lateral view of control and treated zebrafish heads. A, B. WISH analysis shows 
that the expression of bdnf mRNA in different brain territories of the treated larvae is still 
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present 2h after PTZ removal. A’, B’. No difference was observed 24h after PTZ removal. 
Te, telencephalon; To, optic tectum; Tg, tegumentum, Hy, hypothalamus; Rh, 
rhombencephalon.    
     
 
 
In order to validate bndf data by a second independent methodology, I have 
performed RT-qPCR analysis using the total RNA extracted from zebrafish larvae. 
As shown in Figure 3.9, RT-qPCR confirms the statistically significant increase of 
bdnf expression relative to control at the three different time points analysed.  
 
 
 
 
Figure 3.9. RT-qPCR analysis of relative bdnf expression. The graph represents the mean 
of the fold change of the bdnf  gene relative to the control. The error bars represent the 
standard deviation. The asterisks represent the statistically significant value (***p 0.0001; 
**p < 0.001), using Student’s t-test.   
 
 
Since PTZ is an antagonist of GABA A receptors, it has been shown that seizures 
induced by PTZ administration are associated with an alteration of GABA A receptor 
subunit mRNA in different brain areas of rodents (Walsh et al., 1999). Therefore, I 
asked whether PTZ treatment is able to influence genes associated with GABA 
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signalling also in zebrafish brain. To this aim, I have performed RT-qPCR analysis 
for gabra1 gene, that encodes one GABA A receptor subunit. In parallel, I have 
investigated also the transcriptional responses for gad1, another gene involved in 
GABA signalling. The gad1 gene is responsible for GABA synthesis and is 
associated with GABA-mediated synaptic signalling.  
 
As shown in Figure 3.10, the levels of gabra1 and gad1 mRNA were not 
significantly altered at the end of the PTZ treatment. Interestingly, a mild although 
not statistically significant increase of gabra1 and gad1 expression was seen 2h after 
the treatment. At 24h, both genes presented comparable levels of expression with 
respect to controls.  
 
 
 
 
Figure 3.10. RT-qPCR analysis of relative gabra1 and gad1 expression at different time 
points. The graphs represent the mean of the fold change relative to the control. The error 
bars represent the standard deviation. No significant difference, using Student’s t-test (p> 
0.05).  
 
 
 
To summarize this composite set of data, PTZ treatment in 3 dpf zebrafish larvae is 
associated to a very significant locomotory phenotype that is highly indicative of 
seizure occurrence. Moreover, the observed transcriptional responses of c-fos and 
bdnf genes are in line with seizure induction. Interestingly, while gabra1 and gad1 
do not show clear changes of their expression levels at the end of PTZ treatment, a 
mild gad1 upregulation is detected 2h after treatment. Lack of statistical significance 
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in support of the observation of a delayed transcriptional GABA signalling response 
will be further addressed by additional techniques in order to confirm this interesting 
observation. As a matter of fact, the analysis of the specific locomotory and 
transcriptional events that I have analysed in this PhD project reveal that the 
molecular, cellular and behavioural activities altered by PTZ return to basal level 24h 
after the end of the insult. This indicates that the immature brain of zebrafish larvae 
is capable of rapidly recovering its normal physiological condition in a specific 
temporal window.  
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3.2. Temporal Regulation of the Cellular and Transcriptional 
Responses in the Inflammatory Process 
 
 
Inflammation is a natural physiological reaction to different types of insults and its 
role is to re-establish the lost homeostasis. In rodent seizure models, inflammation 
may have a proconvulsive role that may eventually lead to seizure chronicization and 
epilepsy. Therefore, it is particularly important to provide a contribution to the 
dissection of the relationships between the seizure phenotype and the cellular and 
molecular components of the inflammatory response. Remarkably, no data are 
currently available concerning this fundamental biological process in the zebrafish 
PTZ models of seizure.  
 
 
Non-neuronal immune cells 
 
Astrocytes are one of the major types of brain immune cells that are able to respond 
to various insults by changing their morphological, biochemical and transcriptional 
profiles (see Introduction). In addition, astrocytic responses to seizures have been 
described in the brain of various adult rodent models of epilepsy. Differently, seizure 
induction in immature brains provokes changes in the morphology and function of 
astrocytes in a age-dependent manner (see Introduction for references). 
 
With these premises, I have first performed immunohystochemical and gene 
expression studies with the purpose to evaluate the dynamics of astrocyte activity. 
Markers of mammalian astrocytes are glial fibrillary acidic protein (GFAP), an 
intermediate filament protein, and glutamine synthetase (GS), the enzyme that 
converts glutamate in glutamine. In the zebrafish brain, the main GFAP-expressing 
cells occur in the radial glia. These GFAP-positive cells possess properties attributed 
to astrocytes as well as radial glia in mammals. While mammalian astrocytes are 
stellate cells with multiple processes, zebrafish radial glia cell bodies are localized at 
the brain ventricles with a single long process spanning the brain, whereas they 
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shared typical properties with mammalian astrocytes include glutamate re-uptake 
from the synaptic cleft (Oosterhof et al., 2015). Both gfap and gs genes are expressed 
in zebrafish and are used in adult zebrafish brain as markers to label astrocytes and to 
validate the reactive astrocyte states after an insult (Group et al., 2010; Baumgart et 
al., 2012; Schmidt et al., 2014). Using confocal microscopy, I have analysed the 
signal of both astrocytic protein in double whole mount immunohistochemistry 
(WIHC). As shown in Figure 3.11, GS immunoreactivity signal revealed a 
characteristic increased intensity of fluorescence in the region of tectum and in the 
hindbrain (arrows) soon after PTZ removal (T=0). At the same time, GFAP protein 
immunofluorescence showed a localized intensity in the cellular processes present in 
the hindbrain (arrowheads) of PTZ treated zebrafish brain (T=0). 
 
 
 
Figure 3.11. GS and GFAP immunoreactivity in control and PTZ treated zebrafish 
larvae soon after PTZ treatment. The image represents the maximum intensity of the z-
stack analysed using ImageJ. White arrows and arrowheads indicate regions of increased 
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signal. The intensity of the signal is the same for control and treated larvae in each 
experiment.     
 
 
Two hours after PTZ removal (T=2h), GS immunoreactivity in the tectum returned to 
control levels, a change that was observed also in the case of GFAP immunolabelling 
in the cellular processes of the hindbrain (Figure 3.12). 
 
 
 
Figure 3.12. GS and GFAP immunoreactivity in control and PTZ treated zebrafish 
larvae 2h after PTZ treatment (T=2h). The image represents the maximum intensity of the 
z-stack analysed using ImageJ. The intensity of the signal is the same for control and treated 
larvae in each experiment.    
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As well, it was not possible to distinguish any measurable difference between control 
and PTZ treated larvae 24h post treatment (Figure 3.13).  
 
 
 
Figure 3.13.  GS and GFAP immunoreactivity in control and PTZ treated zebrafish 
larvae 24h after treatment (T=24h). The image represents the maximum intensity of the z-
stack analysed using ImageJ. The intensity of the signal is the same for control and treated 
larvae in each experiment.    
 
 
Following, I asked whether the observed immunochemical changes after PTZ 
treatment were associated with changes in the transcriptional activation of these 
genes. To address this question I have performed a RT-qPCR analysis for gfap and 
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gs genes using total RNA extracted from 3 dpf zebrafish larvae. Although the qPCR 
data indicate that there is no statistically significant increase in transcriptional 
activity as an effect of PTZ treatment, gfap expression seem to be affected by PTZ 
treatment, especially in terms of increase at T=0 and following decrease at T=2h. 
Remarkably, also gs expression shows a mild increase at T=0 (Figure 3.14).  
 
 
 
 
 
Figure 3.14. RT-qPCR analyses of relative gfap and gs expression at different time 
points. The graph represents the mean of the fold change relative to the control. The error 
bars represent the standard deviation. Not significant difference, using Student’s t-test (p> 
0.05).  
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Inflammatory molecules  
 
To test the hypothesis that also PTZ induced seizures in 3 dpf zebrafish can stimulate 
IL-1β, IL-6 and TNFα expression, I have performed a gene expression analysis by 
using classical Reverse Transcriptase PCR (RT-PCR) and RT-qPCR. Initially, I have 
demonstrated an increased expression of IL-1β in PTZ-treated zebrafish larvae at 
T=0 using RT-PCR analysis (Figure 3.15). 
 
 
 
 
Figure 3.15. Levels of IL-1β expression at T=0. Gel electrophoresis showing the difference 
in expression of IL-1β mRNA after 45 minutes of PTZ treatment, using RT-PCR analysis.   
 
 
To further extend and quantify this result, I have investigated the expression of the 
IL-1β gene at the three time points considered in this study using RT-qPCR. First, I 
have treated 3 dpf zebrafish larvae with PTZ and extracted the total RNA from the 
whole larvae. As shown in the graph, the relative level of IL-1β expression soon after 
treatment is significantly increased with respect to control, an increase that is 
observed also at 2h post treatment. No significant change was detected 24h after PTZ 
removal (Figure 3.16).  
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Figure 3.16.  RT-qPCR levels of IL-1β expression at the three time points. The graph 
represents the mean of the fold change relative to the control. The error bars represent the 
standard deviation. Asterisks mean statistically significant difference, using Student’s t-test 
(*p< 0.05, **<0.001).  
 
 
 
In order to verify if the transient transcriptional activation of the IL-1β gene is 
capable of activating the other cytokines that are classically stimulated by IL-1β 
signalling, I have performed a RT-qPCR analysis for TNFα and IL-6 genes. As 
shown in Figure 3.17, no significant transcriptional alteration is found, suggesting 
that the increase in IL-1β activity is not sufficient to activate the other cytokines.  
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Figure 3.17. Expression level of TNFα and IL-6 genes at the three time points. The 
graph represents the mean of the fold change relative to the control. The error bars represent 
the standard deviation. No significant difference, using Student’s t-test (p> 0.05).  
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3.3. Analysis of IL-1β involvement in PTZ seizures 
  
 
The transient increase in IL-1β mRNA during and after PTZ treatment suggests a 
possible involvement of IL-1β in seizures. To test this hypothesis, I have performed a 
knockdown experiment by using the morpholino (MO) oligonucleotide-based 
technology in order to block a splicing site of the wild type IL-1β mRNA. The 
sequence of the MO oligomer has been tested in other scientific works where it was 
used to study the involvement of IL-1β in the inflammatory responses to various 
stimuli in zebrafish (Lopez-Mugnoz et al., 2012; Ogryzko et al., 2014). The IL-1β 
splice site MO (IL-1β ssMO) was microinjected at a concentration of 0.5 mM in the 
yolk of embryos at one-cell stage of development. As control, I have microinjected a 
standard control MO (St.CTRL MO). This control morpholino is an oligomer that is 
not able to recognize any other mRNAs in the embryo transcriptome. This is a usual 
method to test the validity of the microinjection technique in zebrafish. As described 
in previous reports, IL-1β ssMO recognizes the splice site between exon 2 and exon 
3, causing intron retention in morpholino-injected embryos. Integration of this intron 
created in-frame premature stop codons that resulted in truncated proteins lacking 
most of the mature carboxy-terminal domain. However, the IL-1β morpholino splice 
site only reduced the expression of wild type mRNA by about 50%, and thus its use 
does not lead to a full functional ablation of this gene.  
 
Figure 3.18 displays the RT-PCR analysis of the mRNA in control and microinjected 
(morphant) larvae. IL-1β ssMo microinjection induced altered splicing of the IL-1β 
transcript, as demonstrated by the presence of two bands in morphant mRNA, of 
which the upper one corresponds to the morpholino-induced variant transcript which 
includes the retention of ~100nt intron 2-3, while the lower band corresponds to the 
properly spliced mRNA. The single band in standard control injected zebrafish 
larvae represents the IL-1β wild type transcript. As described, no altered locomotion 
was observed for IL-1β morphants.  
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Figure 3.18. IL-1β ssMO alters correct splicing of IL-1β transcript in 3 dpf zebrafish 
morphant larvae. Agarose gel showing RT-PCR amplification of cDNA products derived 
from IL-1β transcripts. Amplification product of normal primary transcript expected size: 
700 bp (St.CTRL MO). The inclusion of a 100 bp intron in the IL-1β mRNA of IL-1βssMO-
microinjected larvae is indicated by the red arrow.      
 
 
The result of RT-PCR analysis shows that IL-1β ssMO-microinjected larvae possess 
both wild type and alternative transcript variants, indicating the occurrence of a 
partial IL-1β knockdown. 
 
 
At 3 dpf, IL-1β morphant and St.CTRL MO control larvae were treated with PTZ 
and analysed for locomotory profile by measuring the total distance moved and the 
mean velocity. The protocol utilized is the light on-light off stimuli (see above). 
Figure 3.19 shows that 45 minutes of PTZ treatment cause a significant decrease of 
distance moved compared to control St.CTRL MO larvae, but not variation in terms 
of mean velocity, suggesting that the partial block of the normal synthesis of IL-1β 
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protein may influence, in part, the behavioural responses associated with prolonged 
PTZ treatment.  
 
 
 
 
Figure 3.19. Altered locomotory activity of IL-1β morphant (IL-1β ssMO).  A. The graph 
represents the distance moved and velocity for a total duration of 45 minutes. Circle and 
square symbols represent each larvae and the error bars indicate s.e.m. Asterisks show 
statistically significant difference, using a non parametric Mann-Whitney test (* p < 0.05). B. 
Locomotory tracks that represent the first 5 minutes of recording. 
 
 
 
To address the role of IL-1β in seizure via a different approach, I have tested the 
effect of caspase-1 inhibition on PTZ treatment in wild type larvae using a known 
agent, YVAD, that was previously used to block the catalytic activity of caspase 1 
enzyme in zebrafish (Ogryzko et al., 2014). This inhibitor was applied 3h before the 
PTZ treatment, at two different concentrations, 50 µM (as described before) and 25 
A 
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µM, to estimate a potential dose-response effect. After 3h, PTZ-treated larvae were 
submitted to the same recording assay. As shown in the graph, the block of caspase-1 
generate a more evident decrease of locomotory activity in zebrafish larvae treated 
with PTZ, respect to control larvae, and this effect is dose-dependent (Figure 3.20). 
 
  
 
 
 
Figure 3.20.  The effect of different concentrations of caspase 1 inhibitor (YVAD) on 
locomotory activities of 3 dpf zebrafish larvae treated with PTZ. A. Circle, square and 
triangle symbols represent each larvae and the error bars indicate s.e.m. Asterisks show the 
statistically significant difference, using one-way ANOVA with Dunnett’s post hoc test (* p 
< 0.05, **** p <0.0001). B. Locomotory track that represent the first 5’ of recording.   
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To validate the results obtained by pharmacological inhibition of caspase 1, I have 
performed the same experiment by using a non-selective caspase inhibitor. As shown 
in Figure 3.21, the treatment with a generic pan-caspase inhibitor did not attenuate 
locomotory activities in zebrafish larvae treated with PTZ.  
 
 
 
 
 
Figure 3.21. The effect of YVAD and pan-caspase on locomotory activities of 3 dpf 
zebrafish larvae treated with PTZ. A. The graph represents the distance moved and the 
velocity of PTZ treated larvae after pre-treatment with caspase 1 (50uM) and pan-caspase 
(50uM) inhibitors. Circle, square and triangle symbols represent each larvae and the error 
bars indicate s.e.m. Asterisks mean the statistically significant difference, using one-way 
ANOVA with Dunnett’s post hoc test (* p < 0.05, **** p <0.0001). B. Locomotory track that 
represent the first 5’ of recording.   
 
 
 
 
A 
 66 
 
To verify if the reduced locomotory behaviour generated by IL1β inhibition is 
associated to an alteration of neuronal activity, I have performed a WISH analysis for 
the c-fos gene, although in a single biological replicate. As shown in Figure 3.22, 
concomitant treatment of zebrafish larvae with YVAD and PTZ causes a reduction of 
c-fos gene expression, while no difference was observed in pan-caspase-treated 
larvae respect to PTZ control group.  
 
 
 
 
Figure 3.22. Decreased c-fos expression in YVAD pre-treated larvae after PTZ. WISH 
analysis of c-fos gene in 3 dpf zebrafish larvae treated with pan-caspase (B), YVAD (C) and 
control DMSO (A), soon after PTZ treatment, shows similar pattern between pan-caspase 
and DMSO control treated larvae, while the intensity of c-fos signal is decreased in YVAD 
pre-treated zebrafish larvae. In A, B and C, dorsal view of 3 dpf zebrafish heads.     
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CHAPTER 4 
 
Discussion   
 
The necessity of studying the brain and its physiology represents the goal in the field 
of neuroscience and drives the researchers, since long time, to investigate the 
mechanism of brain function and the processes linked to brain dysfunction. In 
particular, the comprehension of the mechanisms that underlie the brain 
pathophysiology is important for the identification of new targets and for the 
evaluation of therapeutic strategies to various brain diseases and disorders. In this 
respect, animal models offer an invaluable opportunity in this field. Most research 
studies in neurobiology are conducted in rodents and with the aim to mimic the 
human conditions of a particular pathophysiological mechanism. The search for new 
insights about the processes involved in complex conditions has led scientists to 
develop animal models that offer the opportunity to combine the study of brain 
disease mechanisms and to test therapeutic strategies. Zebrafish is a powerful model 
system for modelling a wide range of human disorders in translational neuroscience 
(Steward et al., 2013). In recent years, zebrafish larvae and adults have been used to 
model epilepsy and seizures for CNS drug discovery and to identify novel 
epileptogenic genes by means of forward genetics (Baraban et al., 2005; Baxedale et 
al., 2012, Mussulini et al., 2013). The advantages of using zebrafish larvae to study 
seizures provide novel opportunities in the field of epilepsy research that deserve 
investigation.  
 
 
Seizures in the immature brain 
  
The alteration of gene expression or signalling pathways linked to seizure induction 
and the effect of these changes during embryonic development is one major 
conundrum that attracts an increasing number of investigators. During embryonic 
development, the activity and regulation of gene expression patterns are well 
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orchestrated in order to define the correct maturation and functionality of the 
organism. Disturbance of these mechanisms at a particular stage of embryonic 
development can provoke long lasting effects. Seizures may perturb a wide range of 
developmental phenomena in an activity-dependent manner, including cell division, 
migration, sequential expression of receptors, as well as formation and probably 
stabilization of synapses that are essential for the correct formation and wiring of the 
circuitry, such as the migration of neurons, formation of new synapses (Holmes and 
Ben-Ari, 2001). Studies of the mature epileptic brain have revealed the contribution 
of cellular and molecular factors to seizures expression and epilepsy. How these 
factors alter the functional maturation and development of the immature brain paves 
the way to the unravelling of the susceptibility to seizures and seizure-related 
outcomes in different developmental stages. The immature rat brain has been used to 
study the impact of seizures on the highly regulated developmental processes 
(Holopain, 2008). This model has been used to investigate neuronal vulnerability in 
term of cell loss, cellular and synaptic reorganization, acute and sub-acute cellular 
and molecular alterations, contribution of inflammatory-like reactions and alteration 
of structure and function of inhibitory GABA A and excitatory glutamate receptors.  
 
 
The zebrafish immature brain: an instructive tool to study seizures 
 
The objective of my PhD project is to study seizure-related mechanisms in young 
zebrafish larvae as in vivo model of seizure induction in a functional and 
maturational phase of brain development. One main goal is to assess the validity of 
studying some contributing processes to seizure in immature brain also in zebrafish. 
A wider characterization of hyperexcitability, neuroinflammation and other seizure-
related processes like cell death is required to improve our understanding of the 
zebrafish immature brain model of acute seizures. In perspective, validation of the 
zebrafish immature brain model may represent an instructive tool for a better 
understanding of the potential meaning of seizure related effects on the outcomes of 
brain maturation. For this purpose, I have used a 45 minute-long treatment with a 
known pro-convulsant agent, PTZ, to analyse the behavioural, cellular and 
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transcriptional responses to seizure induction at 72 hpf, a developmental stage that 
corresponds to the early maturation of the brain, with a focus on the recovery timing 
of the normal physiological conditions that includes long term observations. Second, 
I have tried to contribute to the pro- vs anticonvulsive role of the inflammatory 
response by manipulating inflammatory molecules in order to add unprecedented 
information in a non-mammalian model of seizures. 
 
 
Neuronal activation in the PTZ-induced seizure zebrafish larval model 
 
The active state marker c-fos 
 
The expression levels of various genes involved in seizures in mammalian models 
were examined during the development of zebrafish brain. The c-fos gene is one of 
them. It encodes a transcription factor of 56 kDa that is expressed in neuronal and 
non-neuronal cell types in response to a number of different stimuli. It represents one 
of the first known “immediate early genes, IEG” that has been identified. The 
acronym IEG refers to a group of genes with rapid and transient expression with no 
need of de novo protein synthesis (Greer and Greeben, 2008). IEG genes are not 
constitutively expressed, but when their transcription is induced, they are able to 
regulate the activation of “late response genes” that give rise to more detailed 
responses. Upregulation of c-fos expression in neurons of the intact brain was 
observed in specific brain regions in response to seizures and in association with a 
wide range of physiological stimuli by pioneering studies of Morgan and Curran in 
1987. Several studies have demonstrated that the induction of c-fos is a useful tool to 
mark neurons that have been recently activated. The intracellular signalling cascades 
involved in IEG activation in both physiological and pathological conditions have 
been extensively investigated in neurons. Neuronal depolarization generates a strong 
increase of intracellular levels of second messenger cAMP and Ca
2+
 that in turn 
activate intracellular kinases that converge on the phosphorylation of the 
transcription factor CREB. This event activates c-fos mRNA transcription, followed 
by translation into c-fos protein that is able to act as a transcription factor for 
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different neuron-specific genes (reviewed by Flavell and Greenberg, 2008). This 
process occurs rapidly and permits neurons to transform the depolarizing stimuli into 
a different intracellular long-lasting responses, such as the induction of genes 
involved in synaptic plasticity, long-term memory and cell death, critical processes 
for brain development as well as for many cognitive functions in the adult. To better 
define the effect of PTZ treatment in seizure induction, I have performed expression 
analysis for the c-fos transcription factor. The c-fos gene is a marker of neuronal 
activation that provides a functional mapping of brain activity in response to various 
acute or chronic challenges (pro-convulsant agents) (Morgan and Curran, 1987), and 
has been described also in other zebrafish models of seizures (Baraban et al., 2005). 
The c-fos expression is not detected in controls, indicating that this gene is not 
transcriptionally active in normal condition (absence of stimuli). On the contrary, 
PTZ treatment caused a robust induction of c-fos transcription in the brain, 
suggesting that the administration of PTZ in the normal medium generates neuronal 
responses throughout the developing brain. Together with c-fos induction in trunk 
muscle, results indicate generalized seizures caused by PTZ-dependent synaptic 
depolarization. 
 
 
The neurotrophin BDNF 
 
There is a subset of genes activated specifically in response to excitatory synaptic 
transmission that triggers calcium influx into the postsynaptic neuron. Previous 
studies of the transcriptional consequences of exposing in vitro cultured neurons to 
convulsants have demonstrated that other genetic components are expressed in 
addition to synaptic activity-regulated genes like c-fos. One gene whose expression is 
specifically induced by neuronal activity in neurons is the brain-derived neurotrophic 
factor (BDNF). Among other neurotrophins, which are important regulators to CNS 
function, BDNF is the best characterized (Binder and Scharfman, 2004). The 
neurotrophin BDNF is central to many facets of CNS function. BDNF acts as a 
survival- and growth-promoting factor in a variety of neurons (Acheson et al., 1995, 
Huang and Reichardt, 2001). A multitude of stimuli has been described that alter 
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BDNF gene expression in both physiological and pathological states (Lindholm et 
al., 1994). For example, BDNF expression has been shown to increase upon light 
stimulation in visual cortex (Castrén et al., 1992), osmotic stimulation in the 
hypothalamus (Castrén et al., 1995; Dias et al., 2003), and physical exercise in the 
hippocampus (Neeper et al., 1995). BDNF expression is upregulated in epileptic 
animal models, and the time, extent and duration of transcriptional induction depend 
on the type and severity of seizure (reviewed by Patterson, 2001). One of the first 
demonstrations of an activity-dependent transcription of the BDNF gene was 
supported by detection of its mRNA following intense neuronal activity in kainic 
acid-induced seizure (Zafra et al., 1990). Induction of BDNF has been detected also 
in other types of experimentally induced epileptiform activities, as well as 
electrically and chemically induced seizures, including PTZ (Patterson et al., 2001). 
This discovery raised the idea that seizure-induced expression of neurotrophic factors 
may contribute to the alteration of synapsy formation and to the lasting structural and 
functional changes underlying epileptogenesis and the correlated consequences in 
brain functionality. In zebrafish, BDNF is expressed in the brain of 3 dpf larvae, 
suggestive of a functional implication in brain development (De Felice et al., 2014). 
Like c-fos, PTZ treatment induces BDNF upregulation and wider expression across 
the entire brain, within a neuroanatomical distribution similar to that of c-fos 
expression. These results indicate that both c-fos and BDNF gene are 
transcriptionally regulated during seizures in 3 dpf zebrafish larvae. 
 
 
The GABA signalling 
 
GABA is the major neurotransmitter in the mature mammalian brain, and several 
studies have speculated about the changes in the mRNAs levels of its receptor 
subunit after different types of seizures associated with epilepsy processes. In 
particular, prolonged seizures (status epilepticus or SE) result in altered expression 
and membrane localization of several GABAR subunits, associated with changes in 
GABAR-mediated inhibition. Changes in GABAR subunit expression and function 
in epileptic animals precede the development of epilepsy, suggesting that these 
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changes contribute to the epileptogenesis process (Brooks-Kayal et al., 2009). In 
contrast, SE (postnatal day 10) in neonatal rats results in increased GABAR α1 
subunit expression and does not lead to the subsequent development of epilepsy. In 
order to better describe the effect of PTZ treatment, I have verified the transcriptional 
regulation of genes involved in GABA signalling. To this aim, I have selected the 
gad1 gene, responsible of GABA neurotransmitter synthesis, and the gabra1 gene 
that encodes for one subunit of GABAA receptor. The somewhat predictable results 
obtained in my thesis work suggest that PTZ treatment does not influence the normal 
transcriptional activity of both genes. This suggests that the inhibition of GABA 
receptors does not influence the normal transcriptional levels of GABA signalling 
genes. 
 
 
The locomotory profile 
 
Previous studies in zebrafish larvae have shown that seizures induced by PTZ 
treatment cause a robust increase in locomotory activity (Baraban et al., 2005). I 
have analysed the locomotory response associated with PTZ treatment in 3 dpf 
zebrafish larvae using the DanioVision instrument that allows automatized and 
simultaneous recording of the locomotory behaviour of up to 96 larvae. Badexale et 
collegues (2012) have suggested that light exposure is an important parameter for 
high-troughput screening of anti-epileptic drugs so to discriminate the sedative effect 
of compounds that were originally identified as anti-epileptic. Using a protocol of 
continuous light stimuli, I have observed a significant difference in the locomotory 
parameters analysed (total distance moved and mean velocity) between control and 
treated zebrafish larvae. Since little spontaneous swimming of 3 dpf larvae hampers 
the detection and appreciation of the locomotory activity, I have tested the 
locomotory response using a protocol of 10’ light on- 10’ light off. The effect of 
switching on and off the light permits to stimulate a basal activity also in control 
larvae and represents a more precise protocol to describe the locomotory responses to 
treatment. The results obtained with both protocols indicate that treatment of 3 dpf 
zebrafish larvae with 15 mM of PTZ elicits a seizure-like phenotype. Together with 
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the behavioural analysis, my PhD work has produced different molecular, cellular 
and locomotory data that are altogether consistent with a neuronal hyperexcitation 
condition caused by acute seizures.  
 
 
Partial inflammatory response to acute seizures in the zebrafish immature brain  
 
Epilepsy research emphasizes the main role of inflammation and immune mediators 
in seizure and epilepsy. In particular, most attention is devoted to Il-1β signalling. 
However, results in rodent models differ in various respects. In the adult brain, the 
involvement of Il-1β has been studied in epileptogenic models, where this 
inflammatory molecule may eventually contribute to increased threshold for 
spontaneous seizures and neuronal cell loss, processes that are associated with 
alteration of inflammatory factors and immune cells. A double function has been 
proposed for Il-1β in epileptogenic processes (Vezzani et al., 2007), both associated 
with a pro-convulsant action: one rapid effect is mediated by direct activation of 
neurotransmitter receptors; the other is a long term effect generated by the IL-1β 
activation of a classical inflammatory cascade, associated with transcription of other 
inflammatory cytokines (TNFα, IL-6) together with morphological and functional 
changes in glia cells (from resting to active state) that contribute to neuronal injury 
and increased susceptibility to seizure. On the contrary, some age-dependent 
differences are found in the context of the immature brain. First, an increase of 
cytokine levels and glia cell activation are present prominently in P15 and P21 
immature rats and the temporal time of alteration is visible after few hours and 
persist for few days (Rizzi, 2003, Ravizza, 2005). In the postnatal brain, on the 
contrary, IL-1β mRNA is not induced soon after seizures, but the level of expression 
is increased 24h post seizures. As well, GFAP immunoreactivity and microglia 
activation are only weakly induced in the brain at this age (Javela et al., 2011). 
   
I have investigated the mRNA levels of three cytokine coding orthologous genes 
expressed in the mammalian brain, TNFα, IL-1β and IL-6, as well as the activity of 
astrocytic cells by immunohistochemical and transcriptional assays. Interestingly, I 
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have found an increased level of IL-1β mRNA soon after PTZ treatment. This 
increase is not accompanied by significant changes in the level of the two other 
inflammatory cytokines. In parallel, I have observed an increase in the 
immunoreactivity for GFAP and GS proteins, markers of astrocyte cells. The 
presence of increased immunoreactive signals suggests that, during PTZ exposure, 
astrocytes are affected by the alteration of normal brain homeostasis. The 
transcriptional activity of GFAP and GS genes, in addition, is not altered, suggesting 
that PTZ treatment could probably generate morphological and enzymatic changes at 
protein levels and producing self-limiting responses. This finding is more similar to 
responses associated with seizures in the postnatal immature brain of rats, suggesting 
that, in the context of immature zebrafish brain, PTZ-induced seizures is not able to 
generate glial cell reactions at the transcriptional level.  
 
However, the presence of a rapid IL-1β activation that is lasting after acute seizures, 
and the fact that this response is not followed by the classical inflammatory cytokines 
(TNFα and IL-6) in PTZ treated zebrafish larvae, evokes the implication of 
regulatory mechanism for IL-1β expression in the zebrafish PTZ seizures. In adult 
rodent brain, for example, the increase of IL-1β mRNA and protein occurs within 
less of 30 minutes, and decline in time of window 48-72 hours from seizures 
induction (Vezzani et al., 2002), but is followed by the expression of TNFα and IL-6 
cytokines, partially in line with my results. If TNFα and IL-6 inflammatory cytokines 
are not produced, probably the mechanism activated by PTZ seizures induction in 
zebrafish brain could be different from the classical response observed in 
mammalians such that the inflammatory response is limited to the IL-1β molecule.  
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Rapid post-seizure recovery 
 
To study how basal conditions are regained after the end of the acute seizure event, I 
have performed same analyses as above in a short (2h) and long (24h) time window 
after PTZ removal. Interestingly, while c-fos expression and locomotory parameters 
are drastically reduced in the brain already 2h after the end of the PTZ treatment, 
bdnf remains upregulated, though not in a statistically significant manner, also 24h 
after PTZ removal. Therefore, my results provide new insight into the temporal 
consequences of seizure induction. I have found that one prolonged seizure 
associated with 45 minutes treatment with 15 mM PTZ in 3 dpf zebrafish larvae 
produce a long lasting alteration of the transcriptional activity of the bdnf gene in 
different neuronal cell types. The bdnf signal is markedly present in its normal brain 
distribution, and it is extended also in nearby areas. As neurotrophic factor, BDNF 
could elicit neuroprotective effects after seizures to buffer the altered brain context 
and limit neuronal depolarization, as proposed from Greer and Greenberg (2008). 
Further studies are necessary to identify both the neuronal cell types that express 
BDNF, to clarify the role of this neurotrophin and to identify the mechanisms 
involved in the regulation of this gene in seizure. The gabra1 gene was already found 
to be altered for at least 24h in PTZ rodent epilepsy models (Walsh et al., 1999), 
suggesting that variations in GABAA receptor mRNAs after prolonged seizures may 
be associated with alterations in GABAA receptor function and numbers. In 
zebrafish, a mild regulation of gabra1 and gad1 was detected 2h after treatment. 
Although not statistically significant, this slight transcriptional increase is indicative 
of a positive feedback mechanism by which GABA receptor inhibition positively 
regulates GABA signalling homeostasis. Further investigations are needed to better 
understand this mechanism. As to inflammatory molecules, IL-1β increase persists 
also 2h after PTZ removal while it becomes negligible after 24h. Instead, TNFα and 
IL-6 maintain their steady state expression at any time point analysed. Similarly, the 
effect of seizure on inflammatory cell types such as astrocytes is limited after PTZ 
removal, because at 24h post treatment no increased signal in GFAP positive cells 
was found in the zebrafish brain, indicative of a rapid and self-limiting response  (see 
above). 
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The proconvulsive role of IL-1β 
 
In order to gain functional insights into the role of IL-1β in PTZ-induced seizure in 3 
dpf zebrafish larvae, I have performed a genetic and pharmacological analysis. I have 
found that the partial block of the IL-1β protein caused a moderate attenuation in 
term of locomotory activity response in 3 dpf zebrafish IL-1β morphant larvae and 
that this effect is partially rescued by pharmacological approaches. In particular, by 
blocking the production of the IL-1β protein with one specific inhibitor of the 
enzyme caspase 1, I have observed a more prominent attenuation of this behavioural 
response, in support of a direct implication of IL-1β in eliciting seizure-related 
processes. On the contrary, IL-1β morphant treatment with a generic caspase 
inhibitor did not significantly attenuate the loss of locomotory activity observed in 
PTZ treated larvae. Further, I have verified the transcriptional responses of c-fos 
gene after PTZ treatment in larvae pre-treated with these pharmacological inhibitors, 
using WISH (single biological replicate). As shown in the Results chapter, YVAD 
pre-treated zebrafish larvae showed a reduction in c-fos expression upon PTZ 
treatment, suggesting that IL-1β signalling positively contributes to PTZ induced 
seizures in 3 dpf zebrafish larvae. A similar mechanism for IL-1β action has been 
proposed in other models of epilepsy, suggesting the evolutionary conservation of 
this mechanism in zebrafish and mammals. However, these results are only 
preliminary observations and require further investigation.  
 
If confirmed, this result constitutes the first evidence of the proconvulsive role of IL-
1β signalling in PTZ-induced seizures in 3 dpf zebrafish larvae. More questions 
remain open. For example, the short and long term consequences of IL-1β blockade 
in zebrafish behavioural and transcriptional responses in PTZ-induced seizures, as 
well the main cell types involved in this mechanism and the principal targets. At the 
same time, this observation corroborates the value of a new model system to 
investigate the effect of signalling pathways involved in seizure generation.  
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